Document:

Exhibit
10.10

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ADMINISTRATIVE
SUPPORT SERVICES AGREEMENT

 

BETWEEN

 

SPECIALISTS
ON CALL, INC.

 

AND

 

[INSERT
PRACTICE NAME]

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     

    

    

 

ADMINISTRATIVE
SUPPORT SERVICES AGREEMENT

 

This
Administrative Support Services Agreement (the “Agreement”) is made and effective on [INSERT DATE] by
and between Specialists On Call, Inc., a Delaware corporation (“SOC”), and [INSERT PRACTICE NAME],
a [INSERT JURISDICTION] professional corporation (“Practice”) (each a “Party” and
collectively the “Parties”). Many of the capitalized words and phrases used in this Agreement are defined in
Article I, but some are defined in the Section in which they are first used because they are better understood in that
context.

 

RECITALS:

 

WHEREAS
Practice is a professional corporation engaged in the private practice of medicine and support for other professional organizations
in the practice of medicine through its employed and independently contracted physicians, who via telemedicine consultations provide
professional medical diagnosis, evaluation, and therapeutic intervention services in applicable specialty areas, including neurology,
psychiatry, and intensive care, among other activities (the “Medical Services”);

 

WHEREAS
SOC is engaged in the business of providing telemedicine and other equipment and technologies, related support services for hospitals,
and administrative services to physicians and practice groups such as Practice that provide Medical Services;

 

WHEREAS
Practice recognizes that the services provided by SOC are of great value and that Practice can benefit from the availability of
such services;

 

WHEREAS
Practice wishes to provide Medical Services, directly and indirectly, through physicians licensed in various jurisdictions; and

 

WHEREAS
Practice desires to obtain from SOC certain services relating to the business aspects of Practice, and SOC desires to provide
such services.

 

NOW
THEREFORE, in consideration of the mutual covenants and agreements herein contained and incorporating the recitals set forth above,
Practice hereby agrees to contract with SOC for the support services herein described and SOC agrees to contract with Practice
to provide such services according to the terms and conditions provided in this Agreement.

 

ARTICLE
I

DEFINITIONS

 

SECTION
1.1 “Client Facility” shall mean any hospital, health care facility, physician practice, professional
entity, or office throughout the United States under contract with SOC or Practice for the provision of the Medical Services.

 

SECTION
1.2  “Governmental Payor” shall mean those federal health care programs including the Medicare and Medicaid
programs that directly reimburse for Medical Services on a fee-for-service basis. For purposes of this provision, payments made
by a managed care contracting organization on behalf of a Medicare or Medicaid enrollee shall not be considered a Governmental
Payor. This exclusion from the definition of Governmental Payor may include, for example, payments made by Medicare Advantage
(“MA”) organizations or a Medicare or Medicaid health maintenance organization.

 

SECTION
1.3 “Management Account” shall mean such bank account in SOC’s name and owned by SOC at a bank
selected by SOC.

 

    	 	2	 

    

    

 

SECTION
1.4 “Operating Account” shall be the bank account of Practice in which Total Collections received directly
from Governmental Payors and Private Payors may be deposited.

 

SECTION
1.5 “Person” means any natural person, partnership, trust, estate, association, limited liability company,
corporation, custodian, nominee, governmental instrumentality or agency, body politic or any other entity in its own or any representative
capacity.

 

SECTION
1.6 “Practice Expenses” means, in addition to those expenses identified elsewhere herein, the following
operating and non-operating expenses incurred by Practice:

 

1.6.1 Compensation,
benefits and other direct costs (including workers’ compensation and all payroll taxes or charges) of all Physicians;

 

1.6.2 Locums
tenens costs of Practice to the extent such costs are approved by SOC;

 

1.6.3 Ad
valorem and income taxes assessed against Practice;

 

1.6.4 Taxes
directly incurred by Practice in connection with the Medical Services;

 

1.6.5 Malpractice
judgments, awards or settlements not covered fully by any required insurance;

 

1.6.6 Legal
expenses of Practice as approved by SOC; and

 

1.6.7 Costs
of other advisors and consultants engaged to provide services to Practice with respect to its operations or the provision of the
Medical Services.

 

SECTION
1.7 “Private Payor” shall mean all non-Governmental Payors, including private managed care organizations,
health maintenance organizations, MA organizations, self-insured health plans, preferred provider organizations, and workers’
compensation insurance plans, customers and individuals.

 

SECTION
1.8 “Physician” shall mean those individuals who are licensed to practice medicine and who are board
certified and/or board eligible to practice the applicable specialty and trained in the use of telemedicine, as applicable, in
the applicable states where Practice is providing or making available the provision of Medical Services and who are either employees
of or independent contractors to Practice.

 

SECTION
1.9 “Medical Services” has the meaning set forth in the recitals.

 

SECTION
1.10 “Total Collections” shall be defined as the amounts actually received from Client Facilities, Government
Payors, Private Payors, or any other responsible payment source for the Medical Services rendered by Physicians.

 

    	 	3	 

    

    

 

ARTICLE
II

management AND ADMINISTRATIVE services

 

SECTION
2.1 General. Practice hereby appoints SOC as its sole and exclusive administrator of all non-medical, day-to-day
operations and business functions, including business support services, personnel, contracting support, accounting, billing and
payables support, technology, facilities, equipment, pharmacy support, and supplies required for the administrative operation
of Practice (referred to herein as “Administrative Services”) so that Practice may provide the Medical Services,
and SOC hereby agrees to perform such Administrative Services for Practice, as permitted by applicable law and subject to matters
reserved for Practice as herein contemplated. SOC is hereby expressly authorized to perform Administrative Services in whatever
manner it deems reasonably appropriate to meet the non-medical, day-to-day operations and functions of Practice in the provision
of the Medical Services. Notwithstanding SOC’s Administrative Services and other general and specific rights and responsibilities
set forth in this Agreement, Practice (either directly or through its Physicians) shall retain control with respect to all medical
and professional determinations and shall be responsible for the provision of the Services to customers, consumers, patients,
and other health care providers and for the supervision of all licensed medical and health professionals involved in the provision
of the Services by Practice.

 

SECTION
2.2 Recruitment of Physicians. SOC shall assist Practice in the selection and recruitment of Physicians when necessary
to meet the needs of the Client Facilities, carrying out such Administrative Services as may be appropriate such as advertising
for and identifying potential candidates, checking credentials, and arranging interviews; provided, however, that Practice
shall interview and make the ultimate decision as to the suitability of any Physician to become associated with Practice.

 

SECTION
2.3 Income Tax Returns and Financial Statements. SOC shall assist Practice in the preparation of annual income tax
returns for the operations of Practice during the term of this Agreement. Practice shall be solely responsible for payment of
any federal, state, or local income, franchise, social security, unemployment or withholding taxes owed by Practice.

 

SECTION
2.4  Insurance. SOC shall provide advice and assistance to Practice in connection with Practice’s procurement,
management and administration of professional liability insurance for Practice covering each of its Physicians. Such Administrative
Services shall include assisting with and arranging for the collection of premiums for such insurance, assisting Practice with,
and monitoring the performance of, and making recommendations concerning, its actuarial consultants, claims management functions,
specialized legal services and other insurance management services as deemed appropriate in connection with such professional
liability insurance programs; provided, however, SOC shall not be responsible for any claims, losses or judgments
against Practice or its Physicians, whether or not covered by insurance.

 

SECTION
2.5 Billing and Collection Services. SOC shall provide Practice with Administrative Services for all billings and
collections associated with the Medical Services rendered under this Agreement as set forth below:

 

2.5.1 Client
Facility Billing Arrangements. Where Client Facilities pay directly for the Medical Services, SOC shall invoice each such
Client Facility on a monthly basis under the terms and conditions of the Client Facility’s written services agreement.

 

2.5.2 Direct
Payor Billing Arrangements. For Client Facilities where Practice is required to bill and seek payment for Medical Services
directly from patients and/or third-party payors, SOC shall (a) credential and enroll the Physicians with third-party payors including
the Medicare program; (b) code and submit claims for Medical Services rendered in accordance with applicable third-party payor
standards and coding conventions including the American Medical Association CPT-4 and ICD-9 CM (or successor) coding guidelines;
and (c) bill patients and other responsible parties for any coinsurance or deductible payments due.

 

    	 	4	 

    

    

 

2.5.3 Third-Party
Billing Services. Practice acknowledges and agrees that SOC shall be permitted to provide billing services under this Section
directly or under a contractual arrangement with an outside, third-party billing company or agent.

 

SECTION
2.6 Scope of Medical Services. During the term of this Agreement, SOC shall be responsible for on behalf of Practice
and any other professional entities for which Practice is making available Physicians (a) contracting with Client Facilities including
the negotiation of rates and payment terms; (b) determining the types of Medical Services required at each Client Facility; and
(c) evaluating the current and future needs for Medical Services at Client Facilities. To effectuate such authority to execute
such contracts with the Client Facilities, Practice shall enter into a limited power of attorney with SOC (“Limited POA”)
according to the form of Exhibit B, attached hereto and incorporated by reference.

 

SECTION
2.7 Additional Services.

 

2.7.1 SOC
shall negotiate, execute, and administer all managed care and other third-party payor contracts on behalf of Practice and shall
consult with Practice on all professional or clinical matters relating thereto. To effectuate such authority to execute such third-party
payor and managed care contracts, Practice shall enter into the Limited POA.

 

2.7.2 SOC
shall arrange for legal, accounting, and consulting services related to the operation of Practice, the expense for which will
be incurred in the ordinary course of business, including the cost of enforcing any Physician agreement containing restrictive
covenants. However, the costs relating to aspects of malpractice suits against Practice shall be governed by Article VII
hereof. Practice may elect to select alternative legal counsel in the defense of such matters, provided that such counsel is approved
by SOC.

 

2.7.3 SOC
shall consult with Practice regarding the coordination of all advertising, marketing, and promotional services, programs, and
materials in connection with Practice.

 

SECTION
2.8 Exclusions/Adverse Actions. SOC represents and warrants that (a) it is not excluded from participation under
any federal health care program for the provision of items or services for which payment may be made under a federal health care
program; (b) no final adverse action, as such term is defined under 42 U.S.C. 1320(a)-7(c), has occurred or is pending or threatened
against SOC or, to its knowledge, against any employee, contractor or agent engaged to provide items or services under this Agreement;
and (c) that SOC is not under investigation by any federal or state governmental agency in connection with any medical items or
services furnished or billings submitted to any federal health care program (collectively “SOC Exclusions/Adverse Actions”).
During the term of this Agreement, SOC agrees to notify Practice in writing of any SOC Exclusions/Adverse Action within ten (10)
days of learning of any such SOC Exclusions/Adverse Action and provide the basis of the SOC Exclusions/Adverse Actions.

 

SECTION
2.9 Events Excusing Performance. So long as SOC uses its commercially reasonable best efforts, SOC shall not be
liable to Practice for failure to perform any of the services required herein in the event of strikes, lock-outs, calamities, acts
of God, unavailability of supplies or other events over which SOC has no control for so long as such events continue, and for
a reasonable period of time thereafter.

 

    	 	5	 

    

    

 

SECTION
2.10 Limitations on SOC’s Authority. Practice has provided SOC with copies of Practice’s organizational
documents. Except as Practice may specifically authorize from time to time, SOC shall not have the authority to do the following:

 

2.10.1 Any
action that requires the vote or consent of any of Practice’s owner(s), officers, and/or director(s) under Practice’s
organizational documents;

 

2.10.2 Any
action inconsistent with this Agreement or Practice’s organizational documents; or

 

2.10.3 Any
action inconsistent with the policies, procedures and directives of Practice relative to the exercise of the medical or professional
judgment of Practice or its Physicians.

 

SECTION
2.11 Compliance with Applicable Laws. SOC shall comply in all material respects with all applicable federal, state
and local laws, regulations and restrictions in the conduct of its obligations under this Agreement.

 

ARTICLE
III

OBLIGATIONS OF Practice

 

SECTION
3.1 Medical Services and Standards of Service.

 

3.1.1 Practice
and its employed or contracted Physicians shall provide Medical Services for the Client Facilities. In all cases, the turnaround
times for professional services shall be consistent with the terms and conditions of the Medical Services set forth in the contracts
with the Client Facilities (as the same may be modified, amended, supplemented, or restated from time to time).

 

3.1.2 During
the term of this Agreement and with respect to the Medical Services provided hereunder, Practice and its Physicians shall (a)
exercise independent judgment in all areas related to the practice of medicine, subject only to the applicable legal and ethical
obligations; (b) perform duties under this Agreement in accordance with recognized standards of the medical profession and shall
use all reasonable efforts and professional skills and judgment; and (c) ensure that each Physician providing Medical Services
on behalf of Practice or a contracted party of Practice maintains his or her license to practice medicine or provide telemedicine
services in the state(s) or jurisdiction(s) where the Client Facilities for which the Physician is providing Medical Services
are located and that such Physician attend continuing education programs as is consistent with state regulations or otherwise
reasonable and customary to enable such physicians to maintain the appropriate level of certification(s) necessary to provide
the Medical Services required under the terms of this Agreement. Practice shall have the sole responsibility for the professional
direction of all Medical Services provided by Physicians for the Client Facilities. In the event that any disciplinary actions
or malpractice actions are initiated against any Physician, Practice shall immediately inform SOC of such action and the underlying
facts and circumstances.

 

3.1.3 Practice
shall establish the schedule of professional fees charged by Practice for Medical Services (“Service Fee Schedule”).
Notwithstanding the foregoing, SOC shall have the right to review and comment on such Service Fee Schedule in order to assist
Practice in establishing, negotiating, and maintaining a competitive Service Fee Schedule, in accordance with its responsibilities
under Section 2.7.

 

    	 	6	 

    

    

 

SECTION
3.2 Physicians and Supervising Physicians.

 

3.2.1 Practice
shall contract with or employ a sufficient number of Physicians to provide the professional interpretations associated with Medical
Services rendered at each of the Client Facilities under contract with SOC. Practice and SOC shall meet and confer, as necessary
during the term of this Agreement, to evaluate the current and future need for Physicians. Practice shall only enter into professional
services agreements or employment agreement with the number of Physicians agreed upon between SOC and Practice based upon current
or projected needs of the Client Facilities. Practice shall be responsible for the supervision, training, and evaluation of its
Physicians.

 

3.2.2 All
Physicians retained by Practice shall be competent, at all times hold and maintain a valid and unlimited license and/or certification
to provide Medical Services in the state(s) and jurisdiction(s) where the Client Facilities for which the Physician is providing
Medical Services are located, or such other state or jurisdiction as may be applicable, and shall be board-certified or board-eligible
in the applicable specialty.

 

3.2.3 Practice
shall have the responsibility for compensating the Physicians, including the salaries or fringe benefits paid to such individuals
and the withholdings, as required by law, of any sums for income tax, unemployment insurance, social security, or any other withholding
pursuant to any applicable law or governmental requirements; provided, however, SOC shall receive and consent to all compensation
arrangements of the Physicians. During the term of this Agreement, SOC shall, in the name of and on behalf of Practice administer
and pay when due the compensation to the Physicians as a Practice Expense out of the Total Collections.

 

SECTION
3.3 Accounts Receivable Collections

 

3.3.1 Receivables
Collection. In order to facilitate the collection of receivables from Government Payors, Private Payors, and Client Facilities
for Medical Services furnished, Practice shall:

 

3.3.1.1  Establish
an Operating Account for the collection of Total Collections paid by any Governmental Payor, Private Payor, or Client Facility
at a bank designated or approved by SOC; and

 

3.3.1.2  Direct
the bank to transfer, by federal wire fund transfer of immediately available funds, pursuant to the periodic interval requested
by SOC as frequently as each business day (or as otherwise required by SOC), all amounts deposited in each of the Operating Account
to the Management Account or to any other account designated by SOC for the collection of such funds.

 

3.3.2 The
Parties acknowledge and agree that, at all times during the term of this Agreement, Practice shall have sole control over the
Operating Account and may amend, waive, rescind, revoke or terminate the payment disposition instructions above. Notwithstanding
the preceding sentence, in the event that Practice amends, waives, rescinds, revokes or terminates the disposition instructions
above without the prior written consent of SOC, such event shall constitute a material breach by Practice, thereby triggering
SOC’s right to terminate this Agreement immediately under Section 9.3.3 and to take any other actions consistent
with this Agreement.

 

    	 	7	 

    

    

 

SECTION
3.4 Medical Service Reports. As requested by SOC, Practice Physicians shall provide reports which identify all Medical
Services performed (“Report”). Such Report shall identify, among other topics, Medical Services so as to enable
SOC to bill Client Facilities, patients, or third-party payors for the Medical Services rendered under the terms of this Agreement.
Reports, as applicable, shall conform to applicable coding conventions including the American Medical Association CPT-4 and ICD-9
CM (or successor) coding guidelines, and any other applicable standards issued by the American College of Medicine.

 

SECTION
3.5 Credentialing. Practice shall be responsible for monitoring and implementing the credentialing standards established
by SOC and Practice for the credentialing of all Physicians providing Medical Services for the Client Facilities.

 

SECTION
3.6 Participation in Quality Assurance Activities and Performance Improvement Activities. As reasonably requested
by SOC, Practice Physicians shall participate in any quality assurance, utilization review, peer review programs, and performance
improvement programs developed and implemented by SOC, in consultation with the Practice, as well as any compliance or committee
activities established by SOC, in consultation with Practice.

 

SECTION
3.7 Prohibitions Against Certain Transactions. During the term that this Agreement is in effect, approval from SOC
shall be required for the following:

 

3.7.1 Entering
into any merger;

 

3.7.2 The
sale of substantially all (51% or more) of Practice’s stock, membership interests, or assets to a third-party without the
consent of SOC; or

 

3.7.3 Entering
into any indebtedness on behalf of Practice.

 

SECTION
3.8 Exclusions/Adverse Actions. Practice represents and warrants that (a) neither it nor any Physician engaged by
Practice is excluded from participation under any federal health care program for the provision of items or services for which
payment may be made under a federal health care program; (b) no final adverse action, as such term is defined under 42 U.S.C.
1320(a)-7(c), has occurred or is pending or threatened against Practice or, to its knowledge, against any employee, contractor
or agent engaged to provide items or services under this Agreement; and (c) neither Practice nor any of its Physicians are under
investigation by any federal or state governmental agency in connection with any medical items or services furnished or billings
submitted to any federal health care program (collectively “Practice Exclusions/Adverse Actions”). During the
term of this Agreement, Practice agrees to notify SOC in writing of any Practice Exclusions/Adverse Action immediately of learning
of any such Practice Exclusions/Adverse Action and provide the basis of Practice Exclusions/Adverse Actions.

 

ARTICLE
IV

cOMPENSATION

 

SECTION
4.1 Administrative Fee and Direct Costs.

 

4.1.1 For
the Administrative Services rendered by SOC hereunder, in addition to Direct Costs, Practice shall pay SOC a total monthly administrative
fee (the “Administrative Fee”) as set forth in Schedule 4.1 (as amended, modified, or supplemented from
time to time to provide for new jurisdictions and modifications for services, as appropriate upon the mutual agreement of the
Parties without regard to the amendment provisions of this Agreement).

 

    	 	8	 

    

    

 

4.1.2 In
addition to the Administrative Fee, Practice shall pay SOC for certain direct costs incurred by SOC on behalf of Practice, paid
on a pass-through basis (the “Direct Costs”); provided, however, that SOC may in SOC’s sole discretion
defer charging Practice for the Direct Costs covering any period. The Direct Costs include, but are not limited to: (a) payments
on indebtedness incurred by SOC to purchase equipment and technology or otherwise provide funds or other assets to Practice to
do so; (b) the costs of all equipment, technology, and supplies, including leasing, repair, and maintenance costs; (c) salaries,
benefits, payroll taxes and other direct costs of all personnel employed or contracted directly by SOC to provide nurse triage
and consult call center services (as allocated for the Client Facilities contracted with Practice); (d) professional liability
insurance costs of Practice; and (e) third party and regulatory costs and fees for Physician licensing and credentialing.

 

4.1.3 SOC
shall issue an invoice identifying the Administrative Fee and Direct Costs (unless deferred) due for each monthly period during
the term of this Agreement no later than sixty (60) days after the subject month. SOC is hereby granted full power and authority
to pay the Administrative Fee, Direct Costs, and any Operational Loans (defined below) out of Total Collections; provided, however,
that any and all compensation to Physicians shall be paid before the payment of any Administrative Fee or Operational Loans.

 

SECTION
4.2 Practice Expenses. As part of the Administrative Services, SOC shall, for the benefit of Practice, provide for
the payment of Practice Expenses arising from its applicable contracts with the Client Facilities (including compensation to Physicians)
out of Total Collections arising from such Client Facilities.

 

SECTION
4.3 Funding of Deficit; Operational Loan. To the extent the Practice Expenses, Direct Costs, Administrative Fees
or other outstanding amounts owed by Practice to SOC or other third parties incurred by Practice exceed the Total Collections
on a monthly basis, such deficit may be paid by SOC at SOC’s option, and any such payments with appropriate interest as
required or appropriate shall be deemed to be a loan from SOC to Practice (each an, “Operational Loan”). Practice
shall use any and all future Total Collections to repay Operational Loans to SOC until such Operational Loans are paid in full.
SOC shall not seek repayment of Operational Loans from the owner(s) of Practice directly.

 

SECTION
4.4 Security Interest; Control Agreement. Practice hereby grants to SOC a security interest in the accounts receivable
of Practice, including the Total Collections and cash in the Operating Account, Private Receivables Bank Account, and Management
Account for payment of the Services Fee and as satisfaction of any Operational Loan. In addition, Practice shall cooperate with
SOC and execute all necessary documents to perfect such security interest or pledge the same to SOC’s lenders or other third
parties, including, without limitation, a control agreement to perfect SOC’s security interest in the Operating Account.

 

ARTICLE
V

RESTRICTIVE
COVENANTS AND LIQUIDATED DAMAGES

 

The
Parties recognize that SOC has paid a substantial amount in connection with this Agreement and that it will incur substantial
ongoing costs in providing the Administrative Services hereunder and that the continued provision of services by SOC shall be
economically feasible only if Practice operates an active practice to which the Physicians associated with Practice devote their
full time and attention during the hours worked. As such, Practice and its Physicians recognize the need for and agree to abide
by the covenants entered into by them pursuant to this Article V.

 

    	 	9	 

    

    

 

SECTION
5.1 Covenant Not To Compete. Practice agrees and covenants that, beginning on the date of this Agreement and continuing
throughout the term of this Agreement and for a one (1) year period after termination (except in performance under this Agreement
or as otherwise consented to in writing by SOC), Practice will not, and will cause its owner(s), officers, and director(s) not
to, in any manner, directly or indirectly, separately or in conjunction with any other Person (including employees or Affiliates)
in any location throughout the United States of America: (a) act as an employee, independent contractor or consultant for
or in connection with, any business operation that is conducting or preparing to conduct Medical Services; (b) establish, maintain
or own any financial, beneficial or other interest in (other than an interest consisting of less than five percent (5%) of a class
of publicly traded security), or make any loan to or for the benefit of, any business operation that is conducting or preparing
to conduct Medical Services; or (c) render any managerial, consulting, marketing or other business advice to or in connection
with any business operation that is conducting or preparing to conduct Medical Services.

 

SECTION
5.2 Non-Solicitation. The Parties acknowledge and agree that SOC has spent significant time and effort in establishing
its customer and employment relationships with its non-professional personnel. Practice covenants and agrees that, during the
Initial and Renewal Terms of this Agreement and for a period of two (2) years following termination of this Agreement, Practice
shall not, and shall cause its owner(s), agents, employees, and contractors not to, for Practice’s benefit or the benefit
of others, (i) directly or indirectly, solicit business from or enter into a business relationship or transaction with any Client
Facility that has or has had a business relationship with SOC so as to disrupt or attempt to disrupt any relationship, contractual
or otherwise, relating to SOC or (ii) hire or contract for services or induce, or attempt to induce, any employee or independent
contractor of SOC.

 

SECTION
5.3 Enforcement. Practice acknowledges and agrees that since a remedy at law for any breach or attempted breach
of the provisions of this Article V shall be inadequate and damages difficult to ascertain, SOC shall be entitled to specific
performance and injunctive or other equitable relief in case of any such breach or attempted breach. Practice waives any requirement
for the securing or posting of any bond in connection with the obtaining of any such injunctive or other equitable relief. If
any provision of this Article V, relating to the restrictive period, scope of activity restricted and/or geographical area
described therein shall be declared by a court of competent jurisdiction to exceed the maximum time period, scope of activity
restricted or geographical area such court deems reasonable and enforceable under applicable law, the time period, scope of activity
restricted and/or area of restriction held reasonable and enforceable by the court shall thereafter be the restrictive period,
scope of activity restricted and/or the territory applicable to the restrictive covenant provisions in this Article V.
The invalidity or non-enforceability of this Article V in any respect shall not affect the validity or enforceability of
the remainder of this Article V or of any other provisions of this Agreement.

 

SECTION
5.4 Survival. The covenants contained in this Article V shall survive the termination of this Agreement for
any reason and continue in full force and effect for the periods set forth herein.

 

ARTICLE
VI

RECORDS

 

SECTION
6.1 Patient Medical Records.

 

6.1.1 The
Parties acknowledge and agree that all patient medical records in connection with the Medical Services provided for the Client
Facilities shall remain the property of Practice; provided, however, that SOC may request and obtain, in accordance with
applicable law, a copy of all such records at SOC’s sole cost and expense.

 

    	 	10	 

    

    

 

6.1.2 Notwithstanding
the foregoing provision, SOC has the right to transfer some or all of the medical records to any successor or affiliate of Practice
or to any medical group practice or any other entity which, following any termination or cessation of this Agreement with Practice,
serves as the provider entity furnishing services at the Client Facilities.

 

6.1.3 Medical
records shall be maintained for such period(s) of time as required by applicable law and in accordance with the terms and conditions
of the applicable Client Facility contracts. The Parties shall maintain the confidentiality of medical records in accordance with
federal and state laws and use information contained in such records only for the limited purpose necessary to perform the services
set forth herein, as further provided for in Article X hereof.

 

SECTION
6.2 Records Owned by SOC. All records relating in any way to the operation of Practice which are not the property
of Practice under the provisions of Section 6.1 above, shall at all times be the property of SOC.

 

SECTION
6.3 Custody of and Access to Records. On behalf of Practice, SOC shall maintain custody of all files and records
relating to the operation of Practice, including accounting, billing, patient medical records, and collection records; provided.
During the term of this Agreement and for a period of not less than seven (7) years following the date of any termination of this
Agreement, Practice or its designee shall have reasonable access during normal business hours to Practice’s and SOC’s
financial records which relate to Practice, including records of collections, expenses and disbursements as kept by SOC in performing
SOC’s obligations under this Agreement, and Practice may copy any or all such records.

 

ARTICLE
VII

INSURANCE and indemnification

 

SECTION
7.1 Insurance. Throughout the term of this Agreement, SOC will assist Practice in obtaining insurance reasonable
and consistent with market practices for operations similar to the Medical Services in the name of Practice with each of SOC and
Practice as named beneficiaries, including general liability, workers compensation, and professional liability and tail insurance,
as applicable, for Practice and all Physicians engaged by Practice pursuant to the terms and conditions set forth in each such
Physician’s employment agreement or professional services agreement. All such insurance costs for the benefit of Practice
or a Physician of Practice shall be considered a Practice Expense. SOC shall also maintain general liability and workers compensation
insurance at an amount consistent with the provision of SOC’s services under this Agreement.

 

SECTION
7.2 Indemnification. Practice shall indemnify, hold harmless and defend SOC, its owners, officers, directors, and
employees, from and against any and all liability, loss, damage, claim, causes of action, and expenses (including reasonable attorneys’
fees), whether or not covered by insurance, caused or asserted to have been caused, directly or indirectly, by or as a result
of the performance of Medical Services for the Client Facilities or the performance of any intentional acts, negligent acts or
omissions by Practice and/or its member(s), agents, employees and/or subcontractors (other than SOC, or its agents) during the
term hereof. SOC shall indemnify, hold harmless and defend Practice, its owner(s), officers, director(s) and employees, from and
against any and all liability, loss, damage, claim, causes of action, and expenses (including reasonable attorneys’ fees),
whether or not covered by insurance, caused or asserted to have been caused, directly or indirectly, by or as a result of the
performance of any intentional acts, negligent acts or omissions by SOC and/or its Personnel, agents, employees and/or subcontractors
(other than Practice) during the term of this Agreement.

 

    	 	11	 

    

    

 

SECTION
7.3 Rules Regarding Indemnification. The obligations and liabilities of each indemnifying party hereunder with respect
to claims resulting from the assertion of liability by the other party or third parties shall be subject to the following terms
and conditions:

 

7.3.1 The
indemnified party shall give prompt written notice to the indemnifying party of any claim which might give rise to a claim by
the indemnified party against the indemnifying party based on the indemnity agreement contained in Section 7.2 hereof,
stating the nature and basis of said claims and the amounts thereof, to the extent known. If written notice is not given to the
indemnifying party within thirty (30) days from receipt of notice of the claim to be indemnified, in sufficient detail to apprise
the indemnifying party of the nature of the claim (in each instance taking into account the facts and circumstances known by the
indemnified party with respect to such claim), the indemnifying party shall not be liable to the party seeking indemnification
to the extent that the indemnifying party can demonstrate that its rights were irreparably prejudiced thereby. The indemnifying
party shall have the right, at its option, to compromise or defend, at its own expense and by its own counsel, any claim involving
the asserted liability of the party seeking indemnification. If any indemnifying party shall undertake to compromise or defend
any such asserted liability, it shall promptly notify the party seeking indemnification of its intention to do so, and the party
seeking indemnification agrees to cooperate fully with the indemnifying party and its counsel in the compromise of, or defense
against, any such asserted liability. The indemnifying party shall not settle any claim in any manner that would materially affect
the indemnified party without the indemnified party’s prior written consent. All costs and expenses incurred in connection
with such cooperation shall be borne by the indemnifying party. In any event, the indemnified party shall have the right, at its
own expense and by its own counsel to participate in the defense of such asserted liability.

 

7.3.2 The
indemnified party shall not make any settlement of any claims without the written consent of the indemnifying party, which consent
shall not be unreasonably withheld or delayed.

 

ARTICLE
VIII

TRANSFER
AND ASSIGNMENT

 

SECTION
8.1 Assignment by SOC. SOC shall have the right, without Practice’s prior written approval, to assign all
or any portion of this Agreement to any entity controlled by, controlling, or under common control with SOC (its affiliates) or
to any entity that acquires all or substantially all of the assets of SOC.

 

SECTION
8.2 Assignment by Practice Prohibited. Practice shall not have the right to assign its rights and obligations hereunder
unless otherwise permitted under the terms of this Agreement or upon the prior written consent of SOC. Any sale of Practice, merger
by Practice, or the sale of any assets of Practice shall be considered a prohibited assignment by Practice.

 

SECTION
8.3 Effect of Prohibited Assignment. Any prohibited assignment hereunder shall be deemed an event of termination
of this Agreement.

 

ARTICLE
IX

TERM
AND TERMINATION

 

SECTION
9.1 Term of Agreement. This Agreement shall commence on the date hereof and shall remain in effect for a period
of five (5) years (the “Initial Term”). Unless terminated earlier pursuant to the terms hereof, this Agreement
shall automatically renew for one (1) year terms (collectively the “Renewal Term”), unless either Party delivers
to the other, not less than ninety (90) days prior to the expiration of the preceding term, written notice of its intent not to
renew.

 

    	 	12	 

    

    

 

SECTION
9.2 Termination by Practice. Practice may terminate this Agreement as follows:

 

9.2.1 In
the event of a filing of a petition in voluntary bankruptcy or an assignment for the benefit of creditors by SOC, or upon other
action taken or suffered, voluntarily or involuntarily, under any federal or state law for the benefit of debtors by SOC, except
for the filing of a petition in involuntary bankruptcy against SOC which is dismissed within ninety (90) days thereafter, Practice
may give notice of the immediate termination of this Agreement;

 

9.2.2 In
the event SOC shall materially default in the performance of any duty or obligation imposed upon it by this Agreement, and such
default shall continue for a period of thirty (30) days after written notice thereof has been given to SOC by Practice (or if
not reasonably curable within such thirty (30) day period and if SOC is proceeding diligently and in good faith and such default
is curable, up to sixty (60) days), Practice may terminate this Agreement;

 

SECTION
9.3 Termination by SOC. SOC may terminate this Agreement as follows:

 

9.3.1 In
the event of a filing of a petition in voluntary bankruptcy or an assignment for the benefit of creditors by Practice, or upon
other action taken or suffered, voluntarily or involuntarily, under any federal or state law for the benefit of debtors by Practice,
except for the filing of a petition in involuntary bankruptcy against Practice which is dismissed within ninety (90) days thereafter;

 

9.3.2 In
the event Practice shall materially default in the performance of any duty or obligation imposed upon it by this Agreement, and
such default shall continue for a period of thirty (30) days after written notice thereof has been given to Practice by SOC (or
if not reasonably curable within such thirty (30) day period and if Practice is proceeding diligently and in good faith and such
default is curable, up to sixty (60) days);

 

9.3.3 Immediately,
at the election of SOC, in the event of any change by Practice in the payment disposition instructions relating to the Operating
Account, in contravention of the terms of this Agreement;

 

9.3.4 Without
cause upon one hundred twenty (120) days’ written notice to Practice;

 

9.3.5 Immediately,
at the election of SOC, in the event of a final Practice Exclusions/Adverse Action unless, in the case of a Physician engaged
by Practice, such individual is removed from providing Medical Services for the Client Facilities promptly but in no event less
than ten (10) days after such action;

 

9.3.6 Immediately,
at the election of SOC, in the event that any owner of Practice breaches any other agreement entered into by Practice and SOC
or in the event of termination of any other agreement entered into between Practice and SOC, or an affiliate of SOC;

 

9.3.7 Immediately
upon any prohibited transfer as provided in Section 8.3 hereof; and

 

9.3.8 Immediately,
upon the dissolution of Practice.

 

    	 	13	 

    

    

 

SECTION
9.4 Effect of Termination.

 

9.4.1 Notwithstanding
the foregoing, this Agreement remains in full force and effect and all obligations hereunder remain enforceable, including any
assignment of Total Collections from Practice to SOC throughout the time period when a material breach has been alleged until
termination is effective (the “Termination Date”). The assignment of Total Collections for any Medical Services
for the Client Facilities furnished on or before the Termination Date shall remain enforceable by SOC until such funds have been
collected by SOC or SOC elects to discontinue collection efforts. Practice acknowledges that SOC shall have a continued assignment
of all right, title and interest in and to the Total Collections for Medical Services furnished before the Termination Date and
Practice shall take no action to prevent or set aside such assignment. Provided, however, SOC shall have no further obligation(s)
to pay for Practice Expenses of Practice arising on or occurring after the Termination Date.

 

9.4.2 Termination
of this Agreement shall not release or discharge either Party from any obligation, debt or liability which shall have previously
accrued and remains to be performed upon the Termination Date, including with respect to Article IV, Article V,
Article VI, Section 7.2, this Section 9.4, Article X, Article XI, and Section 12.14.

 

ARTICLE
X

Patient privacy; hipaa

 

SECTION
10.1 HIPAA Obligations. The Parties acknowledge and agree that, under the Health Insurance Portability and Accountability
Act of 1996 and any regulations promulgated thereunder (collectively, “HIPAA”) and under similar state laws
and regulations, SOC and Practice may, from time to time, have certain obligations respecting security and the confidentiality
of “protected health information,” as that term is defined by HIPAA. SOC and Practice agree that SOC shall perform
its obligations under this Agreement in compliance with HIPAA and other applicable state laws and regulations, and SOC and Practice
shall enter into and be bound by the Business Associate Addendum, attached to this Agreement at Exhibit B and herein incorporated
by reference.

 

SECTION
10.2 HIPAA Modifications. To the extent required by current or future final regulations adopted pursuant to HIPAA,
the Parties agree to revise this Agreement as necessary to conform to these requirements.

 

ARTICLE
XI

INTELLECTUAL
PROPERTY

 

SECTION
11.1  Trademark License.

 

11.1.1 License
Grant. Subject to the conditions and obligations set forth in this Agreement, SOC hereby grants to Practice, and Practice
hereby accepts, a non-exclusive license (the “License”) to use the name “SOC” and “Specialists
on Call”, related logos, and distinguishing trade dress (collectively, the “Mark”) in connection with
Practice’s provision of the Medical Services to Client Facilities. Practice is authorized to use the Mark solely in connection
with Practice’s provision of the Medical Services to Client Facilities and has no right to utilize the Mark for any other
purpose without SOC’s prior written consent.

 

    	 	14	 

    

    

 

11.1.2 Ownership
of Mark. Practice acknowledges that SOC is the sole and exclusive owner of the Mark and has established goodwill associated
with the Mark. Practice agrees that it shall take no action inconsistent with such ownership by SOC and that all uses of the Mark
by Practice shall inure to the benefit of and shall be on behalf of SOC. Nothing contained in the Agreement shall give Practice
any right, title or interest in the Mark other than the right to use the Mark pursuant to the terms of this Agreement. Practice
shall not directly or indirectly register or cause to be registered in any country or governmental subdivision any trademark,
service mark or trade name that is the same as or confusingly similar to the Marks, or any part thereof.

 

11.1.3 Form
of Use. Practice agrees that its use of the Mark shall conform in every material respect with all commercially reasonable
directions for the use thereof given to it by SOC, from time to time, including the proper placement of the Mark on any advertising
and promotional materials and as to the proper use of the Mark in any trade name, corporate name or name of partnership or other
entity in which Practice chooses to use the Mark. In addition, Practice agrees to use the Mark in compliance with all applicable
federal, state and local laws and regulations.

 

11.1.4 Term
and Termination of Trademark License. The License granted herein shall commence on the date of this Agreement and continue
in full force and effect throughout the term of this Agreement. Termination of the License. Upon termination of the License provided
herein, all rights and privileges granted to Practice hereunder shall immediately terminate and Practice shall immediately discontinue
all uses of the Mark and any words or symbols confusingly similar to the Mark. Practice shall promptly return to SOC all printed
materials bearing the Mark. Practice further agrees that all rights in the Mark and the goodwill connected therewith shall remain
the property of SOC at all times.

 

SECTION
11.2 Other Intellectual Property. Without limiting any of the provisions of Section 11.1 hereof, any
Intellectual Property developed by SOC in connection with the provision of SOC’s services set forth in this Agreement or
otherwise shall remain the exclusive property of SOC. Practice’s right to use such Intellectual Property of SOC shall be
limited to such use(s) permitted by this Agreement or as otherwise agreed to in writing by SOC. As used herein, the term “Intellectual
Property” shall mean all forms of intellectual property rights and protections, including all right, title and interest
in and to all: (a) letters patent and all filed, pending or potential applications for letters patent, including any reissue,
reexamination, division, continuation or continuation-in-part applications throughout the world now or hereafter filed or issued;
(b) trade secrets, and all trade secret rights and equivalent rights arising under the common law, state law, federal law and
laws of foreign countries; (c) copyrights and all other literary property or authors' rights, whether or not protected by
copyright, under common law, state law, federal law and laws of foreign countries; and (d) trademarks, trade names, service
marks, symbols, logos, brand names and other proprietary indicia of the Party or third-party under common law, state law, federal
law or laws of foreign countries.

 

ARTICLE
XII

GENERAL PROVISIONS

 

SECTION
12.1 Independent Relationship. Practice and SOC intend to act and perform as independent contractors, and the provisions
hereof are not intended to create any partnership, joint venture, agency or employment relationship between the Parties, except
as may otherwise be set forth in this Agreement. Each Party shall be solely responsible for and shall comply with all state and
federal laws pertaining to employment taxes, income withholding, unemployment compensation contributions and other employment
related statutes applicable to that Party.

 

    	 	15	 

    

    

 

SECTION
12.2 Whole Agreement, Modification. This Agreement, including all Exhibits and Schedules hereto, constitutes the
entire agreement between the Parties. There are no other agreements or understandings, written or oral between the Parties regarding
this Agreement and the Exhibits, other than as set forth herein. This Agreement shall not be modified or amended except by a written
document executed by both Parties to this Agreement, and such written modification(s) shall be attached hereto; provided, however,
that Schedule 4.1 may be amended, updated, modified or supplemented, as appropriate, pursuant to the terms of this Agreement
without a written modification executed by both Parties.

 

SECTION
12.3 Notices. All notices and instruments required or permitted by this Agreement shall be in writing and shall
be addressed as follows:

 

		(a)	If
to Practice:

 

[INSERT
PRACTICE NAME]

[INSERT
PRACTICE ADDRESS]

 

		(b)	If
to SOC:

 

Specialists
On Call, Inc.

1768
Business Center Drive, Suite #100

Reston,
VA 20190

 

With
copy to:

 

Jones
Day

Attention:
Alexis S. Gilroy

51
Louisiana Avenue, NW

Washington,
DC 20001

agilroy@jonesday.com

 

or
to such other mailing address or email address as either Party shall notify the other.

 

SECTION
12.4 Binding on Successors. This Agreement shall be binding upon the Parties hereto, and their successors, assigns,
heirs and beneficiaries.

 

SECTION
12.5 Waiver of Provisions. Any waiver of any terms and conditions hereof must be in writing, and signed by the Parties
hereto. The waiver of any of the terms and conditions of this Agreement shall not be construed as a waiver of any other terms
and conditions hereof.

 

SECTION
12.6 SOC Activities. The Parties acknowledge that SOC is not authorized or qualified to engage in any activity which
may be construed or deemed to constitute the practice of medicine. To the extent any act or service required of SOC in this Agreement
should be construed or deemed, by any governmental authority, agency or court to constitute the practice of medicine, the performance
of said act or service by SOC shall be deemed waived and forever unenforceable.

 

SECTION
12.7 Severability. The provisions of this Agreement shall be deemed severable and if any portion shall be held invalid,
illegal or unenforceable for any reason, the remainder of this Agreement shall be effective and binding upon the Parties.

 

    	 	16	 

    

    

 

SECTION
12.8 Additional Documents. Each of the Parties hereto agrees to execute any document or documents that may be requested
from time to time by the other Party to implement or complete such Party’s obligations pursuant to this Agreement.

 

SECTION
12.9 Attorneys’ Fees. If legal action is commenced by either Party to enforce or defend its rights under this
Agreement, the prevailing party in such action shall be entitled to recover its costs and reasonable attorneys’ fees in
addition to any other relief granted.

 

SECTION
12.10 Contract Modifications for Prospective Legal Events. In the event any state or federal laws or regulations,
now existing or enacted or promulgated after the effective date of this Agreement, are interpreted by judicial decision or regulatory
agency or legal counsel in such a manner as to indicate that the structure of this Agreement may be in violation of such laws
or regulations, Practice and SOC shall amend this Agreement as necessary to eliminate such violation. To the maximum extent possible,
any such amendment shall preserve the underlying economic and financial arrangements between Practice and SOC. To the extent the
Parties cannot agree on any such amendment or changes, the matter shall be submitted to mediation upon the request of either Party
in accordance with Section 12.16 and through the mediation process an equitable modification shall be implemented
based on all of the facts and circumstances. In the event an equitable modification cannot be determined under which this Agreement
will comply with applicable law as determined by either Party’s legal counsel, then upon prior written notice of one Party
to the other, this Agreement will terminate.

 

SECTION
12.11 Remedies Cumulative; Survivability. No remedy set forth in this Agreement or otherwise conferred upon or reserved
to any Party shall be considered exclusive of any other remedy available to any Party, but the same shall be distinct separate
and cumulative and may be exercised from time to time as often as occasion may arise or as may be deemed expedient. Pursuit of
any remedy set forth in this Agreement shall not preclude pursuit of any other remedy provided in this Agreement or any other
remedy provided for in this Agreement constitute a waiver of any amount due from a defaulting party under this Agreement or of
any damages accruing by reason of the violation of any of its terms, provisions and covenants. No waiver of any violation shall
be deemed or construed to constitute a waiver of any other violation or breach of any of the terms, provisions and covenants contained
in this Agreement, and forbearance to enforce one or more of the remedies provided on an event of default shall not be deemed
or construed to constitute a waiver of such default or of any other remedy provided for in this Agreement. The termination of
this Agreement shall not affect the remedies and rights of a Party hereunder with respect to a breach of this Agreement occurring
on or before such termination.

 

SECTION
12.12 Language Construction; Interpretation. The language in all parts of this Agreement shall be construed, in
all cases, according to its fair meaning, and not for or against either Party hereto. The Parties acknowledge that each Party
and its counsel have reviewed and revised this Agreement and that the normal rule of construction to the effect that any ambiguities
are to be resolved against the drafting party shall not be employed in the interpretation of this Agreement. Whenever the words
“include,” “includes” or “including” are used in this Agreement, they will be deemed to be
followed by the words “without limitation.” Whenever the words “herein” or “hereunder” are
used in this Agreement, they will be deemed to refer to this Agreement as a whole and not to any specific Section, unless otherwise
indicated. The terms herein defined in the singular will have a comparable meaning when used in the plural, and vice versa. The
masculine, feminine and neuter genders used herein will include each other gender.

 

SECTION
12.13 No Obligation to Third Parties. None of the obligations and duties of SOC or Practice under this Agreement
shall in any way or in any manner be deemed to create any obligation of SOC or of Practice to, or any rights in, any Person or
entity not a party to this Agreement.

 

    	 	17	 

    

    

 

SECTION
12.14 Confidentiality. Except for disclosure to its owners, affiliates and related parties, and to its (and its
owners’, affiliates’ and related parties’) attorneys, accountants, bankers, underwriters or lenders, neither
Party hereto, nor its agents, owners, affiliates or related parties, shall disclose to any third party the existence of any information
regarding any provision of this Agreement, or any financial information regarding the other (past, present or future) that was
obtained by the other in the course of the negotiation of this Agreement or in the course of the performance of this Agreement,
without the other Party’s written approval; provided, however, the foregoing shall not apply to information which (i) is
generally available to the public other than as a result of a breach of confidentiality provisions, (ii) becomes available on
a non-confidential basis from a source other than the other Party, or its affiliates or agents, which source was not itself bound
by a confidentiality agreement, or (iii) which is required to be disclosed by law, including securities laws or pursuant to court
order. Notwithstanding the foregoing, (a) Practice may disclose information it deems advisable to the Physicians and its Member(s)
provided such individuals are advised of the confidential nature of such information and agree to keep such information confidential
as provided herein and SOC shall be a third-party beneficiary of such agreements and (b) SOC or its affiliates may disclose any
such information in connection with negotiations with other parties in a reorganization, capital or joint venture transaction
involving substantial assets of or equity interests in SOC or its owners, affiliates or related parties or of such other parties.
Each Party hereto shall be responsible and liable for breaches of this Section by such Party or its employees, agents, owners,
affiliates, or related parties.

 

SECTION
12.15 Counterpart Executions; Facsimiles. This Agreement may be executed in any number of counterparts with the
same effect as if all of the Parties had signed the same document. Such executions may be transmitted to the Parties by facsimile
and such facsimile execution shall have the full force and effect of an original signature. All fully executed counterparts, whether
original executions or facsimile executions or a combination, shall be construed together and shall constitute one and the same
agreement.

 

SECTION
12.16  Governing Law; Dispute Resolution. This Agreement shall be governed in all respects, including validity, interpretation
and effect, by the substantive laws of the State of Delaware, without regard to its choice of law principles.

 

12.16.1 Negotiation.
The Parties shall attempt, in good faith, to resolve any controversy, claim, or dispute arising out of this Agreement through
negotiations. Any dispute shall be referred promptly to the level of management of each Party authorized to resolve the dispute.

 

12.16.2 Arbitration.
Any controversy or claim arising out of or relating to this Agreement, with the exception of injunctive relief sought by any party
to this Agreement, not resolved between the Parties through good faith negotiations pursuant to Section 12.16.1, shall
be settled by binding arbitration, which shall be conducted in Washington, DC, in accordance with the American Health Lawyers
Association Alternative Dispute Resolution Service Rules or Procedures for Arbitration by a sole arbitrator, and judgment on the
award rendered by the arbitrator may be entered in any court having jurisdiction thereof. The prevailing party in an arbitration
proceeding will be entitled to reimbursement of reasonable attorney’s fees and all reasonable costs and expenses incurred
in connection with such arbitration.

 

SECTION
12.17 Compliance. Each Party shall comply with all applicable federal, state, and local laws during the term of
this Agreement. In furtherance thereof, each Party warrants that it shall comply with all applicable local, state, federal and
international laws, executive orders, regulations, ordinances, or similar requirements of the national government or government
entity which may now or hereafter govern the performance of the Parties hereunder. This includes the laws of the United States
pertaining to the federal health care programs’ Anti-Kickback Statute (42 U.S.C. § 1320a-7b), the Physician Self-Referral
or “Stark Law” (42 U.S.C. § 1395nn), and other applicable standards of ethical conduct pertaining to gratuities,
gifts, entertainment, and employment of government officials and other requirements

 

SECTION
12.18 Exhibits. The Exhibits to this Agreement, each of which is incorporated by reference, are:

 

Exhibit
A Limited Power of Attorney

 

 Exhibit
B Business Associate Addendum

 

[Signature
Page Follows]

 

    	 	18	 

    

    

 

IN
WITNESS WHEREOF, the Parties hereto have executed this Agreement effective as of the day and year first above written.

 

	 	[INSERT
    PRACTICE NAME]
	 	a
    [INSERT JURISDICTION] professional corporation
	 	 	 
	 	By:	                                 
	 	Name:	 
	 	Title:	 

 

	 	SPECIALISTS
    ON CALL, INC.,
	 	a
    Delaware corporation
	 	 	 
	 	By:	                                 
	 	Name:	 
	 	Title:	 

 

 

[SIGNATURE
PAGE TO ADMINISTRATIVE SUPPORT SERVICES AGREEMENT]

 

     

    

    

 

EXHIBIT A

 

Limited
Power of Attorney

 

STATE
OF _________________

COUNTY
OF _____________________

 

LIMITED
POWER OF ATTORNEY

 

Know
all men by these presents that I, [INSERT NAME], President of [INSERT PRACTICE NAME] (the “Practice”),
by these presents do hereby make, constitute, and appoint SPECIALISTS ON CALL, INC. (“SOC”) the true and lawful
attorney-in-fact, for Practice and in Practice’s name and stead, giving unto said attorney-in-fact power to act in Practice’s
name, place and stead in any way which Practice could do with respect to the following matters to the extent that Practice is
permitted by law to act through an agent, to do and perform the following matters and things:

 

In
accordance with Section 2.6 and Section 2.7 of the Administrative Support Services Agreement by and between Practice and
SOC effective [INSERT DATE], SOC shall have the authority to negotiate, execute and administer all customer agreements
and arrangements and all managed care and other third-party payor contracts on behalf of Practice including the authority to execute
contracts on behalf and in the name of Practice.

 

This
Limited Power of Attorney shall be a Durable Limited Power of Attorney and shall not be affected by my subsequent incapacity or
mental incompetence.

 

And
I do hereby ratify and confirm on behalf of Practice all things so done by Practice’s said attorney-in-fact, within the
scope of the authority herein given SOC, as fully and to the same extent as if by done and performed directly by Practice.

 

[Signature
Page Follows]

 

     

    

    

 

IN
WITNESS WHEREOF, I have hereunto set my Hand and Seal this ___ day of ________________ 20__.

 

	 	[INSERT PRACTICE NAME]
	 	 
	 	_____________________________(SEAL)
	 	[INSERT NAME]
	 	President

 

STATE
OF _________________

COUNTY
OF _____________________

 

I,
the undersigned, a Notary Public of the aforesaid County and State, do hereby certify that [INSERT NAME] personally appeared
before me this day and acknowledged the due execution of the foregoing instrument.

 

Witness
my hand and official stamp or seal, this ___ day of _____________, 20__.

 

_____________________________________

Notary
Public

 

My
Commission Expires:

 

_______________________

[Official
Seal]

 

 

[SIGNATURE
PAGE TO LIMITED POWER OF ATTORNEY]

 

     

    

    

 

EXHIBIT B

 

BUSINESS
ASSOCIATE AGREEMENT

 

This
Business Associate Agreement (the “Agreement”) is made effective on [INSERT DATE], by and between [INSERT
PRACTICE NAME], a [INSERT JURISDICTION] professional corporation, hereinafter referred to as “Covered Entity,”
and Specialists on Call, Inc., a Delaware corporation, hereinafter referred to as “Business Associate”
(individually, a “Party” and collectively, the “Parties”).

 

WITNESSETH:

 

WHEREAS,
the Parties wish to enter into a Business Associate Agreement to ensure compliance with the Privacy and Security Rules of the
Health Insurance Portability and Accountability Act of 1996 (“HIPAA Privacy and Security Rules”) (45 C.F.R. Parts
160 and 164); and

 

WHEREAS,
the Health Information Technology for Economic and Clinical Health (“HITECH”) Act of the American Recovery and Reinvestment
Act of 2009, Pub. L. 111-5, modified the HIPAA Privacy and Security Rules (hereinafter, all references to the “HIPAA Privacy
and Security Rules” include all amendments thereto set forth in the HITECH Act and any accompanying regulations); and

 

WHEREAS,
the Parties have entered into a written or oral arrangement or arrangements (the “Underlying Agreements”) whereby
Business Associate will provide certain services to Covered Entity that require Business Associate to create, receive, maintain,
or transmit Protected Health Information on Covered Entity’s behalf, and accordingly Business Associate may be considered
a “business associate” of Covered Entity as defined in the HIPAA Privacy and Security Rules; and

 

WHEREAS,
Business Associate and Covered Entity wish to comply with the HIPAA Privacy and Security Rules, and Business Associate wishes
to honor its obligations as a business associate to Covered Entity.

 

THEREFORE,
in consideration of the Parties’ continuing obligations under the Underlying Agreements, and for other good and valuable
consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties agree to the provisions of this Agreement.

 

Except
as otherwise defined herein, any and all capitalized terms in this Agreement shall have the definitions set forth in the HIPAA
Privacy and Security Rules. In the event of an inconsistency between the provisions of this Agreement and mandatory provisions
of the HIPAA Privacy and Security Rules, as amended, the HIPAA Privacy and Security Rules in effect at the time shall control.
Where provisions of this Agreement are different than those mandated by the HIPAA Privacy and Security Rules, but are nonetheless
permitted by the HIPAA Privacy and Security Rules, the provisions of this Agreement shall control.

 

		I.	PERMITTED
                                         USES AND DISCLOSURES BY BUSINESS ASSOCIATE

 

A. Business
Associate may use or disclose Protected Health Information to perform functions, activities, or services for, or on behalf of,
Covered Entity as specified in the Underlying Agreements, provided that such use or disclosure would not violate the HIPAA Privacy
and Security Rules if done by Covered Entity.

 

    	 	B-1	 

    

    

 

B. Business
Associate may use Protected Health Information in its possession for its proper management and administration and to fulfill any
present or future legal responsibilities of Business Associate, provided that such uses are permitted under state and federal
confidentiality laws.

 

C. Business
Associate may disclose Protected Health Information in its possession to third parties for the purposes of its proper management
and administration or to fulfill any present or future legal responsibilities of Business Associate, provided that:

 

1. the
disclosures are required by law; or

 

2. Business
Associate obtains reasonable assurances from the third parties to whom the Protected Health Information is disclosed that the
information will remain confidential and be used or further disclosed only as required by law or for the purpose for which it
was disclosed to the third party, and that such third parties will notify Business Associate of any instances of which they are
aware in which the confidentiality of the information has been breached.

 

D. Until
such time as the Secretary issues regulations pursuant to the HITECH Act specifying what constitutes “minimum necessary”
for purposes of the HIPAA Privacy and Security Rules, Business Associate shall, to the extent practicable, access, use, and request
only Protected Health Information that is contained in a limited data set (as defined in 45 C.F.R. § 164.514(e)(2)), unless
Business Associate requires certain direct identifiers in order to accomplish the intended purpose of the access, use, or request,
in which event Business Associate may access, use, or request only the minimum necessary amount of Protected Health Information
to accomplish the intended purpose of the access, use, or request.

 

		II.	OBLIGATIONS
                                         AND ACTIVITIES OF BUSINESS ASSOCIATE

 

A. Business
Associate agrees not to use or further disclose Protected Health Information other than as permitted or required by this Agreement
or the Underlying Agreements or as required by law.

 

B. Business
Associate agrees to use appropriate safeguards and to comply, where applicable, with 45 C.F.R. Part 164, Subpart C with respect
to Electronic Protected Health Information, to prevent use or disclosure of Protected Health Information other than as provided
for by this Agreement. Specifically, Business Associate will:

 

1. implement
the administrative, physical, and technical safeguards set forth in 45 C.F.R. §§ 164.308, 164.310, and 164.312 that
reasonably and appropriately protect the confidentiality, integrity, and availability of any Protected Health Information that
it creates, receives, maintains, or transmits on behalf of Covered Entity, and, in accordance with 45 C.F.R. § 164.316, implement
and maintain reasonable and appropriate policies and procedures to enable it to comply with the requirements outlined in 45 C.F.R.
§§ 164.308, 164.310, and 164.312; and

 

2. report
to Covered Entity any Security Incident, and any use or disclosure of Protected Health Information that is not provided for by
this Agreement, of which Business Associate becomes aware.

 

    	 	B-2	 

    

    

 

C. Business
Associate shall require each subcontractor that creates, receives, maintains, or transmits Protected Health Information on its
behalf to enter into a business associate agreement or equivalent agreement containing the same restrictions on access, use, and
disclosure of Protected Health Information as those applicable to Business Associate under this Agreement. Furthermore, to the
extent that Business Associate provides Electronic Protected Health Information to a subcontractor, Business Associate shall require
such subcontractor to comply with all applicable provisions of 45 C.F.R. Part 164, Subpart C.

 

D. Business
Associate agrees to comply with any requests for restrictions on certain disclosures of Protected Health Information to which
Covered Entity has agreed in accordance with 45 C.F.R. § 164.522 of which Business Associate has been notified by Covered
Entity.

 

E. If
Business Associate maintains a designated record set on behalf of Covered Entity, at the request of Covered Entity and in a reasonable
time and manner, Business Associate agrees to make available Protected Health Information required for Covered Entity to respond
to an individual’s request for access to his or her Protected Health Information in accordance with 45 C.F.R. § 164.524.
If Business Associate maintains Protected Health Information in an electronic designated record set, it agrees to make such Protected
Health Information available electronically to Covered Entity or, upon Covered Entity’s specific request, to the applicable
individual or to a person or entity specifically designated by such individual, upon such individual’s request.

 

F. If
Business Associate maintains a designated record set on behalf of Covered Entity, at the request of Covered Entity and in a reasonable
time and manner, Business Associate agrees to make available Protected Health Information required for amendment by Covered Entity
in accordance with the requirements of 45 C.F.R. § 164.526.

 

G. Business
Associate agrees to document any disclosures of Protected Health Information, and to make Protected Health Information available
for purposes of accounting of disclosures, as required by 45 C.F.R. § 164.528.

 

H. If
Business Associate is to carry out one or more of Covered Entity’s obligations under 45 C.F.R. Part 164, Subpart E, Business
Associate shall comply with the requirements of Subpart E that apply to Covered Entity in the performance of such obligation(s).

 

I. Business
Associate agrees that it will make its internal practices, books, and records relating to the use and disclosure of Protected
Health Information received from, or created or received by Business Associate on behalf of, Covered Entity, available to the
Secretary, in a time and manner designated by the Secretary, to enable the Secretary to determine Business Associate’s or
Covered Entity’s compliance with the HIPAA Privacy and Security Rules. Business Associate also shall cooperate with the
Secretary and, upon the Secretary’s request, pursuant to 45 C.F.R. § 160.310, shall disclose Protected Health Information
to the Secretary to enable the Secretary to investigate and review Business Associate’s or Covered Entity’s compliance
with the HIPAA Privacy and Security Rules.

 

J. Unless
expressly authorized in the Underlying Agreements, Business Associate shall not:

 

1. use
Protected Health Information for marketing or fundraising; or

 

2. use
or disclose Protected Health Information in exchange for remuneration of any kind, whether directly or indirectly, financial or
non-financial, other than such remuneration as Business Associate receives from Covered Entity in exchange for Business Associate’s
provision of the services specified in the Underlying Agreements.

 

    	 	B-3	 

    

    

 

		III.	BusiNESS
                                         ASSOCIATE’S MITIGATION AND BREACH NOTIFICATION OBLIGATIONS

 

A. Business
Associate agrees to mitigate, to the extent practicable, any harmful effect that is known to Business Associate of a use or disclosure
of Protected Health Information by Business Associate in violation of the requirements of this Agreement.

 

B. Following
the discovery of a Breach of Unsecured Protected Health Information (“Breach”), Business Associate shall notify Covered
Entity of such Breach without unreasonable delay and in no case later than thirty (30) calendar days after discovery of the Breach,
and shall assist in Covered Entity’s breach analysis process, including risk assessment, if requested. A Breach shall be
treated as discovered by Business Associate as of the first day on which such Breach is known to Business Associate or, through
the exercise of reasonable diligence, would have been known to Business Associate. The Breach notification shall be provided to
Covered Entity in the manner specified in 45 C.F.R. § 164.410(c) and shall include the information set forth therein to the
extent known. If, following the Breach notification, Business Associate learns additional details about the Breach, Business Associate
shall notify Covered Entity promptly as such information becomes available. Covered Entity shall determine whether Business Associate
or Covered Entity will be responsible for providing notification of any Breach to affected individuals, the media, the Secretary,
and/or any other parties required to be notified under the HIPAA Privacy and Security Rules or other applicable law. If Covered
Entity determines that Business Associate will be responsible for providing such notification, Business Associate may not carry
out notification until Covered Entity approves the proposed notices in writing.

 

C. Notwithstanding
the provisions of Section III.B., above, if a law enforcement official states to Business Associate that notification of a Breach
would impede a criminal investigation or cause damage to national security, then:

 

1. if
the statement is in writing and specifies the time for which a delay is required, Business Associate shall delay such notification
for the time period specified by the official; or

 

2. if
the statement is made orally, Business Associate shall document the statement, including the identity of the official making it,
and delay such notification for no longer than thirty (30) days from the date of the oral statement unless the official submits
a written statement during that time.

 

Following
the period of time specified by the official, Business Associate shall promptly deliver a copy of the official’s statement
to Covered Entity.

 

D. Business
Associate shall bear Covered Entity’s costs of any Breach and resultant notifications, if applicable, to the extent the
Breach arises from Business Associate’s negligence, willful misconduct, violation of law, violation of the Underlying Agreements,
or violation of this Agreement.

 

		IV.	OBLIGATIONS
                                         OF COVERED ENTITY

 

A. Upon
request of Business Associate, Covered Entity shall provide Business Associate with the notice of privacy practices that Covered
Entity produces in accordance with 45 C.F.R. § 164.520.

 

B. Covered
Entity shall provide Business Associate with any changes in, or revocation of, permission by an individual to use or disclose
Protected Health Information, if such changes could reasonably be expected to affect Business Associate’s permitted or required
uses and disclosures.

 

    	 	B-4	 

    

    

 

C. Covered
Entity shall notify Business Associate of any restriction on the use or disclosure of Protected Health Information to which Covered
Entity has agreed in accordance with 45 C.F.R. § 164.522, and Covered Entity shall inform Business Associate of the termination
of any such restriction, and the effect that such termination shall have, if any, upon Business Associate’s use and disclosure
of such Protected Health Information.

 

		V.	TERM
                                         AND TERMINATION

 

A. Term.
The Term of this Agreement shall be effective as of the date first written above, and shall terminate upon later of the following
events: (i) in accordance with Section V.C., when all of the Protected Health Information provided by Covered Entity to Business
Associate or created or received by Business Associate on behalf of Covered Entity is returned to Covered Entity or destroyed
(and a certificate of destruction is provided) or, if such return or destruction is infeasible, when protections are extended
to such information; or (ii) upon the expiration or termination of the last of the Underlying Agreements.

 

B. Termination.
Upon either Party’s knowledge of a material breach by the other Party of its obligations under this Agreement, the non-breaching
Party shall, within twenty (20) days of that determination, notify the breaching Party, and the breaching Party shall have thirty
(30) days from receipt of that notice to cure the breach or end the violation. If the breaching Party fails to take reasonable
steps to effect such a cure within such time period, the non-breaching Party may terminate this Agreement and the Underlying Agreements
without penalty.

 

Where
either Party has knowledge of a material breach by the other Party and determines that cure is infeasible, prior notice of the
breach is not required, and the non-breaching Party shall terminate the portion of the Underlying Agreements affected by the breach
without penalty.

 

C. Effect
of Termination.

 

1. Except
as provided in paragraph 2 of this subsection C., upon termination of this Agreement, the Underlying Agreements or upon request
of Covered Entity, whichever occurs first, Business Associate shall return or destroy all Protected Health Information received
from Covered Entity, or created or received by Business Associate on behalf of Covered Entity. This provision shall apply to Protected
Health Information that is in the possession of subcontractors of Business Associate. Neither Business Associate nor its subcontractors
shall retain copies of the Protected Health Information except as required by law.

 

2. In
the event that Business Associate determines that returning or destroying the Protected Health Information is infeasible, Business
Associate shall provide within ten (10) days to Covered Entity notification of the conditions that make return or destruction
infeasible. Upon mutual agreement of the Parties that return or destruction of Protected Health Information is infeasible, Business
Associate, and its applicable subcontractors, shall extend the protections of this Agreement to such Protected Health Information
and limit further uses and disclosures of such Protected Health Information to those purposes that make the return or destruction
infeasible, for so long as Business Associate and its applicable subcontractors maintain such Protected Health Information.

 

		VI.	MISCELLANEOUS

 

A. No
Rights in Third Parties. Except as expressly stated herein or in the HIPAA Privacy and Security Rules, the Parties to this
Agreement do not intend to create any rights in any third parties.

 

    	 	B-5	 

    

    

 

B. Survival.
The obligations of Business Associate under Section V.C. of this Agreement shall survive the expiration, termination, or cancellation
of this Agreement, the Underlying Agreements, and/or the business relationship of the Parties, and shall continue to bind Business
Associate, its agents, employees, contractors, successors, and assigns as set forth herein.

 

C. Amendment.
The Parties agree that this Agreement will be amended automatically to conform to any changes in the HIPAA Privacy and Security
Rules as are necessary for each of them to comply with the current requirements of the HIPAA Privacy and Security Rules and the
Health Insurance Portability and Accountability Act, unless a particular statutory or regulatory provision requires that the terms
of this Agreement be amended to reflect any such change. In those instances where an amendment to this Agreement is required by
law, the Parties shall negotiate in good faith to amend the terms of this Agreement within sixty (60) days of the effective date
of the law or final rule requiring the amendment. If, following such period of good faith negotiations, the Parties cannot agree
upon an amendment to implement the requirements of said law or final rule, then either Party may terminate this Agreement and
the Underlying Agreements upon ten (10) days written notice to the other Party. Except as provided above, this Agreement may be
amended or modified only in a writing signed by the Parties.

 

D. Assignment.
Neither Party may assign its respective rights and obligations under this Agreement without the prior written consent of the other
Party.

 

E. Independent
Contractor. None of the provisions of this Agreement are intended to create, nor will they be deemed to create, any relationship
between the Parties other than that of independent parties contracting with each other solely for the purposes of effecting the
provisions of this Agreement and any other agreements between the Parties evidencing their business relationship. Nothing in this
Agreement creates or is intended to create an agency relationship.

 

F. Governing
Law. To the extent this Agreement is not governed exclusively by the HIPAA Privacy and Security Rules or other provisions
of federal statutory or regulatory law, it will be governed by and construed in accordance with the laws of the state in which
Covered Entity has its principal place of business.

 

G. No
Waiver. No change, waiver, or discharge of any liability or obligation hereunder on any one or more occasions shall be deemed
a waiver of performance of any continuing or other obligation, or shall prohibit enforcement of any obligation, on any other occasion.

 

H. Interpretation.
Any ambiguity of this Agreement shall be resolved in favor of a meaning that permits Covered Entity and Business Associate to
comply with the HIPAA Privacy and Security Rules.

 

I. Severability.
In the event that any provision of this Agreement is held by a court of competent jurisdiction to be invalid or unenforceable,
the remainder of the provisions of this Agreement will remain in full force and effect.

 

J. Notice.
Any notification required in this Agreement shall be made in writing to the representative of the other Party who signed this
Agreement or the person currently serving in that representative’s position with the other Party.

 

K. Certain
Provisions Not Effective in Certain Circumstances. The provisions of this Agreement relating to the HIPAA Security Rule shall
not apply to Business Associate if Business Associate does not receive, create, maintain, or transmit any Electronic Protected
Health Information from or on behalf of Covered Entity.

 

L. Entire
Agreement. This Agreement constitutes the entire understanding of the Parties with respect to the subject matter hereof and
supersedes all prior agreements, oral or written. In the event of any inconsistency between this Agreement and any other agreement
between the Parties concerning the use and disclosure of Protected Health Information and the Parties’ obligations with
respect thereto, the terms of this Agreement shall control.

 

M. Counterparts.
This Agreement may be executed in any number of counterparts with the same effect as if all of the Parties had signed the same
document. Such executions may be transmitted to the Parties by facsimile and such facsimile execution shall have the full force
and effect of an original signature. All fully executed counterparts, whether original executions or facsimile executions or a
combination, shall be construed together and shall constitute one and the same agreement.

 

[Signature
Page Follows]

 

    	 	B-6	 

    

    

 

IN
WITNESS WHEREOF, the Parties have duly executed this Addendum on the day and year first above written.

 

	 	[INSERT
    PRACTICE NAME]
	 	a
    [INSERT JURISDICTION] professional corporation
	 	
	 
	 	By:	 
	 	Name:	                                 
	 	Title:	 

 

	 	SPECIALISTS
    ON CALL, INC.,
	 	a
    Delaware corporation
	 	 	 
	 	By:	 
	 	Name:	            
	 	Title:	 

 

 

[SIGNATURE
PAGE TO BUSINESS ASSOCIATE AGREEMENT]

 

     

    

    

 

SCHEDULE
4.1

 

Administrative
Fee

 

For
the Administrative Services rendered by SOC hereunder, in addition to Direct Costs, Practice shall pay SOC a total monthly administrative
fee equal to [INSERT AMOUNT] multiplied by the average number of Client Facilities under contract with the Practice during
the subject month (the “Administrative Fee”) for each month during the term of this Agreement.Exhibit 10.11

  

SOC
TELEMED

 

1768
Business Center Drive, Suite 100, Reston, Virginia 20190

 

June
24, 2020

 

John
Kalix

[****]

 

		Re:	EMPLOYMENT
AGREEMENT

 

Dear
John:

 

This
Employment Agreement (the “Agreement”) between you (referred to hereinafter as the “Executive”)
and Specialists On Call, Inc., a Delaware corporation d/b/a SOC Telemed (the “Company”), sets forth
the terms and conditions that shall govern the period of Executive’s employment with the Company (referred to hereinafter
as “Employment” or the “Employment Period”).

 

1. Duties
and Scope of Employment.

 

(a) At-Will
Employment. Executive will commence full-time Employment with the Company effective as of no later than August 15, 2020
(such actual start date, the “Start Date”), the terms of which will be governed by this Agreement. Executive’s
Employment with the Company is for no specified period and constitutes “at will” employment. As a result, Executive
is free to terminate Employment at any time, with or without advance notice, and for any reason or for no reason. Similarly, the
Company is free to terminate Executive’s Employment at any time, with or without advance notice, and with or without Cause
(as defined below). Furthermore, although terms and conditions of Executive’s Employment with the Company may change over
time, nothing shall change the at-will nature of Executive’s Employment.

 

(b) Position
and Responsibilities. During the Employment Period, the Company agrees to employ Executive, initially in the position
of President and transitioning to the position of Chief Executive Officer within six (6) months of the Start Date (the “Transition”).
Executive will report initially to the Company’s interim Chief Executive Officer (the “Interim CEO”)
and, after the Transition, to the Company’s Board of Directors (the “Board”), and Executive will
work out of the Company’s office in Virginia. Executive will perform the duties and have the responsibilities and authority
customarily performed and held by an employee in Executive’s position or as otherwise may be assigned or delegated to Executive
by the Board (or, prior to the Transition, the Interim CEO), so long as any such assigned or delegated duties, responsibilities
and authorities are consistent with Executive’s role as President or Chief Executive Officer, as applicable.

 

     

     

    

 

(c) Obligations
to the Company. During the Employment Period, Executive shall perform Executive’s duties faithfully and to the best
of Executive’s ability and will devote Executive’s full business efforts and time to the Company. During the Employment
Period, without the prior written approval of the Board (or, prior to the Transition, the Interim CEO), Executive shall not render
services in any capacity to any other Person and shall not act as a sole proprietor or partner of any other Person or own more
than five percent (5%) of the stock of any other corporation. Notwithstanding the foregoing, Executive may serve on civic or charitable
boards or committees, deliver lectures, fulfill speaking engagements, teach at educational institutions, or manage personal investments
without advance written consent of the Board (or, prior to the Transition, the Interim CEO); provided that such activities do
not individually or in the aggregate interfere with the performance of Executive’s duties under this Agreement or create
a potential business or fiduciary conflict. Executive shall comply with the Company’s policies and rules, as they may be
in effect from time to time during Executive’s Employment.

 

(d) Business
Opportunities. During Executive’s Employment, Executive shall promptly disclose to the Company each business opportunity
of a type, which based upon its prospects and relationship to the business of the Company or its affiliates, the Company might
reasonably consider pursuing. In the event that Executive’s Employment is terminated for any reason, the Company or its
affiliates shall have the exclusive right to participate in or undertake any such opportunity on their own behalf without any
involvement by or compensation to Executive under this Agreement.

 

(e) No
Conflicting Obligations. Executive represents and warrants to the Company that Executive is under no obligations or commitments,
whether contractual or otherwise, that are inconsistent with Executive’s obligations under this Agreement or that would
otherwise prohibit Executive from performing Executive’s duties with the Company. In connection with Executive’s Employment,
Executive shall not use or disclose any trade secrets or other proprietary information or intellectual property in which Executive
or any other Person has any right, title or interest and Executive’s Employment will not infringe or violate the rights
of any other Person. Executive represents and warrants to the Company that prior to the Start Date Executive shall have returned
all property and confidential information belonging to any prior employer.

 

2. Cash
and Incentive Compensation.

 

(a) Base
Salary. The Company shall pay Executive, as compensation for Executive’s services, a base salary at a gross annual
rate of $450,000, less all required tax withholdings and other applicable deductions, in accordance with the Company’s
standard payroll procedures. The annual compensation specified in this subsection (a), together with any increases in such
compensation that the Company may make from time to time, is referred to in this Agreement as the “Base Salary.”
Executive’s Base Salary will be subject to review and may be increased (but not decreased) as part of the Company’s
normal performance review practices. Effective as of the date of any increase to Executive’s Base Salary, the Base Salary
as so increased shall be considered the new Base Salary for all purposes of this Agreement.

 

    -2-

     

    

 

(b) Cash
Incentive Bonus. Executive will be eligible for an annual cash incentive bonus (the “Cash Bonus”)
each calendar year during the Employment Period based upon the achievement of certain objective and/or subjective criteria (collectively,
the “Performance Goals”). In compliance with all relevant legal requirements and based on Executive’s
level within the Company, the Performance Goals for Executive’s Cash Bonus for a particular year will be established by
the Board or the Compensation Committee of the Board (the “Committee”) and mutually agreed by Executive;
provided, however, that in no event will the subjective portion of the Performance Goals exceed 25% of the Performance Goals overall.
The target opportunity for any such Cash Bonus will be 50% of Executive’s Base Salary (the “Target Bonus”
and such percentage, the “Target Bonus Percentage”), and Executive will be deemed to have earned 100%
of the Target Bonus if 100% of the Performance Goals are attained, as reasonably determined in good faith by the Board or the
Committee, as applicable. In the event the Company and/or Executive achieves more or less than 100% of the Performance Goals,
the Cash Bonus will be increased or decreased in a straight-line linear interpolation method, subject to applicable threshold
and maximum achievement levels set forth in the Performance Goals. Except as set forth in Section 6, Executive shall not earn
a Cash Bonus unless Executive is employed by the Company on the date when such Cash Bonus is actually paid by the Company, which
shall be consistent with Company practice as in effect from time to time and no later than five (5) business days after the certification
of such achievement of the Performance Goals, as applicable. Executive’s Target Bonus and/or Target Bonus Percentage will
be subject to review and may be increased (but not decreased) as part of the Company’s normal performance review practices.

 

(c) Guaranteed
2020 Cash Incentive Bonus. With respect to the calendar 2020 Cash Bonus period, the Company shall pay Executive at least
50% of the Target Bonus (the “Guaranteed Bonus”), to be paid at such time as Cash Bonuses are paid in
accordance with normal Company practice for the payment of earned annual bonuses for its senior executives. Except as set forth
in Section 6, Executive shall not earn such Cash Bonus unless Executive is employed by the Company on the date when such Cash
Bonus is actually paid by the Company.

 

(d) Change
in Control Bonuses.

 

(i) In
the event of a Change in Control of the Company (as defined below), Executive shall be entitled to receive a cash bonus payment
(a “Change in Control Bonus”) in an amount equal to (x) four percent (4%), multiplied by (y)
the amount by which (A) the Net Proceeds exceeds (B) the Company’s equity value calculated based on an enterprise
value of $175,000,000 plus the amount of any additional financing contributed to the Company for operating or capital expenditures
after the date hereof but prior to the date of the Change in Control (the amount determined in accordance with this clause (y),
the “Change in Control Profit”).

 

(ii) Except
as set forth in Section 6, subject to Executive’s continued service to the Company through each relevant vesting date, Executive’s
right to receive twenty-five percent (25%) of the Change in Control Bonus shall vest on the twelve (12) month anniversary of the
Start Date, and Executive’s right to receive one forty-eighth (1/48th) of the Change in Control Bonus shall vest
on the corresponding day of each calendar month thereafter (and if there is no corresponding day, the last day of the month),
so that the Change in Control Bonus will be fully vested four (4) years from the Start Date.

 

    -3-

     

    

 

(iii) Notwithstanding
Section 2(d)(ii), Executive’s right to receive 100% of the Change in Control Bonus shall automatically accelerate and become
fully vested in the event of a Change in Control prior to the fourth anniversary of the Start Date, so long as Executive remains
employed by the Company through the date of the Change in Control, but subject to Section 6.

 

(iv) In
addition to the Change in Control Bonus, in the event of a Change in Control of the Company, Executive shall be entitled to receive
a second cash bonus payment (a “Change in Control Bonus Kicker”) in an amount equal to (x) half
of one percent (0.5%), multiplied by (y) the Change in Control Profit, multiplied by (z) the applicable Performance
Vesting Percentage set forth below, so long as Executive remains employed by the Company through the date of the Change in Control,
but subject to Section 6. For purposes of the following table, “WP Investors Return” means the Net Proceeds
payable to the WP Investors and “Base Amount” means the aggregate amount the WP Investors have invested
in the Company between January 1, 2014, and the date of the Change in Control.

 

	WP
    Investors Return on the Base Amount	Performance
    Vesting Percentage
	Less
    than 1.5 times the Base Amount	0%
	1.5
    times to 2.5 times the Base Amount	0%
    (at 1.5 times) to 100% (at 2.5 times), calculated using linear interpolation (e.g., at 2.2 times, the Performance Vesting
    Percentage would be 70%)
	More
    than 2.5 times the Base Amount	100%

  

(v) Any
Change in Control Bonus and Change in Control Bonus Kicker due under this Section 2(d) shall be paid to Executive within 30 days
following the Change in Control, net of all applicable tax withholdings and other applicable deductions, in the same proportion
of cash, Securities (as defined below) and Non-Cash Proceeds (as defined below) as received by the Company’s stockholders.
In the event any Net Proceeds are received after the date of the Change in Control (e.g., by reason of any escrow or earn-out),
the portion of the Change in Control Bonus and/or Change in Control Bonus Kicker due under this Section 2(d) attributable to such
Net Proceeds shall be paid to Executive within 30 days after any such Net Proceeds are distributed, net of all applicable tax
withholdings and other applicable deductions, in the same proportion of cash, Securities and Non-Cash Proceeds as received by
the Company’s stockholders.

 

    -4-

     

    

 

(vi) For
purposes of this Agreement, “Net Proceeds” means the aggregate amount of (w) cash (including
earn-outs and escrows actually received), plus (x) the fair market value (as determined in the reasonable and good faith
judgment of the Board) of marketable and freely transferable securities (including securities restricted solely by applicable
securities laws) (“Securities”), plus (y) other property (“Non-Cash Proceeds”),
in each case actually received by the Company’s stockholders in respect of the equity of the Company held by them (A)
prior to such Change in Control, in connection with any dividends/distributions (including by way of a “dividend recapitalization”)
actually received in respect of the equity of the Company, plus (B) in connection with such Change in Control, minus (z)
any transaction, monitoring, investment banking, legal, accounting and similar fees, costs and expenses made in connection with
such Change in Control (excluding the Change in Control Bonus and Change in Control Bonus Kicker).

 

(vii) For
purposes of this Agreement, “Change in Control” means the occurrence, in a single transaction or in
a series of related transactions, of any one or more of the following events:

 

(1) any
Exchange Act Person becomes the Owner, directly or indirectly, of securities of the Company representing more than fifty percent
(50%) of the combined voting power of the Company’s then outstanding securities other than by virtue of a merger, consolidation
or similar transaction. Notwithstanding the foregoing, a Change in Control will not be deemed to occur (A) on account of
the acquisition of securities of the Company directly from the Company or its authorized underwriter or broker; (B) on
account of the acquisition of securities of the Company by an investor, any affiliate thereof or any other Exchange Act Person
that acquires the Company’s securities in a transaction or series of related transactions the primary purpose of which is
to obtain financing for the Company through the issuance of equity securities; or (C) solely because the level of Ownership
held by any Exchange Act Person (the “Subject Person”) exceeds the designated percentage threshold of
the outstanding voting securities as a result of a repurchase or other acquisition of voting securities by the Company reducing
the number of shares outstanding, provided, however, that if a Change in Control would occur (but for the operation of this sentence)
as a result of the acquisition of voting securities by the Company, and after such share acquisition, the Subject Person becomes
the Owner of any additional voting securities that, assuming the repurchase or other acquisition had not occurred, increases the
percentage of the then outstanding voting securities Owned by the Subject Person over the designated percentage threshold, then
a Change in Control will be deemed to occur;

 

(2) there
is consummated a merger, consolidation or similar transaction involving (directly or indirectly) the Company and, immediately
after the consummation of such merger, consolidation or similar transaction, the stockholders of the Company immediately prior
thereto do not Own, directly or indirectly, either (A) outstanding voting securities representing more than fifty percent
(50%) of the combined outstanding voting power of the surviving corporation, partnership, limited liability company or other entity
(“Entity”) in such merger, consolidation or similar transaction; or (B) more than fifty percent
(50%) of the combined outstanding voting power of the parent of the surviving Entity in such merger, consolidation or similar
transaction; or

 

    -5-

     

    

 

(3) there
is consummated a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated assets of
the Company and its subsidiaries, other than a sale, lease, license or other disposition of all or substantially all of the consolidated
assets of the Company and its subsidiaries to an Entity, more than fifty percent (50%) of the combined voting power of the voting
securities of which are Owned by stockholders of the Company in substantially the same proportions as their Ownership of the outstanding
voting securities of the Company immediately prior to such sale, lease, license or other disposition.

 

(4) Notwithstanding
the foregoing definition, the term Change in Control will not include (A) a sale of assets, merger or other transaction
effected exclusively for the purpose of changing the domicile of the Company; or (B) a public offering and sale of equity
securities of the Company, or any of its subsidiaries, or their respective successors for cash pursuant to an effective registration
statement (other than on Form S-4, S-8 or a comparable form) under the Securities Act of 1933, as amended from time to time, and
the rules and regulations promulgated thereunder, or any related restructuring or the Transaction. Notwithstanding the foregoing,
to the extent necessary to avoid the imposition of adverse taxation under Section 409A of the Code, in no event will a Change
in Control be deemed to have occurred if such transaction is not also a “change in the ownership or effective control of”
the Company or “a change in the ownership of a substantial portion of the assets of” the Company as determined under
Treasury Regulation Section 1.409A-3(i)(5).

 

(viii) For
purposes of this Agreement, “Exchange Act Person” means any natural person, Entity or “group”
(within the meaning of Section 13(d) or 14(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)),
except that “Exchange Act Person” will not include (A) the Company or any Subsidiary; (B) any employee
benefit plan of the Company or any Subsidiary or any trustee or other fiduciary holding securities under an employee benefit plan
of the Company or any Subsidiary; (C) an underwriter temporarily holding securities pursuant to an offering of such securities;
(D) an Entity Owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as
their Ownership of stock of the Company; or (E) any natural person, Entity or “group” (within the meaning of
Section 13(d) or 14(d) of the Exchange Act) that, as of the date of determination, is the Owner, directly or indirectly, of securities
of the Company representing more than fifty percent (50%) of the combined voting power of the Company’s then outstanding
securities.

 

(ix) For
purposes of this Agreement, “Own,” “Owned,” “Owner,”
“Ownership” and words of like effect mean a person or Entity’s ownership of securities if such
person or Entity, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or
shares voting power, which includes the power to vote or to direct the voting, with respect to such securities.

 

    -6-

     

    

 

(x) For
purposes of this Agreement, “WP Investors” means, collectively, WPXI Finance, LP, Warburg Pincus XI
Partners, L.P. and each investment fund managed by or affiliated with Warburg Pincus LLC or any of its affiliates.

 

(e) Full
Value Award. In the event the Company enters into an acquisition transaction with Healthcare Merger Corp., a Delaware
corporation (the “Transaction”), prior to the occurrence of a Change in Control, then (x) Executive
shall no longer be entitled to the Change in Control Bonus or the Change in Control Bonus Kicker under Section 2(d), and (y)
the Company shall, or shall cause the surviving corporation to, grant Executive a full value equity award (either in the form
of restricted stock or restricted stock units) comprising the following components (collectively, the “Full Value
Award”):

 

(i) Base
Full Value Award. A full value award in respect of a number of shares of the surviving corporation’s common stock equal
to three percent (3%) of fully diluted ownership in the surviving corporation, measured as of the grant date (the “Base
Full Value Award”). The Base Full Value Award will vest as to twenty-five percent (25%) of the shares subject to
the Base Full Value Award on the twelve (12) month anniversary of the Start Date, and as to one sixteenth (1/16th)
of the shares subject to the Base Full Value Award on the corresponding day of each third (3rd) month thereafter (and
if there is no corresponding day, the last day of such month), so that the Full Value Award will be fully vested four (4) years
from the Start Date, subject to Executive continuing to provide services to the surviving corporation and its affiliates through
each relevant vesting date, but subject to Section 6.

 

(ii) Sponsor
Promote Earnout Award. A full value award equal to fifteen percent (15%) of the proceeds related to the Sponsor Promote
Earnout Shares (as defined below) (the “Sponsor Award”), which shall be paid to Executive as and when
such proceeds are paid to the Sponsor (as defined below) pursuant to the terms of the Sponsor Promote Earnout Shares, subject
to Executive continuing to provide services to the surviving corporation and its affiliates through each relevant date, but subject
to Section 6. “Sponsor Promote Earnout Shares” means the aggregate number of shares of the surviving
corporation’s capital stock held by HCMC Sponsor LLC, a Delaware limited liability company (the “Sponsor”),
that are subject to forfeiture unless the volume weighted average price of the surviving corporation’s common stock exceeds
certain thresholds as set forth in the definitive agreements for the Transaction.

 

(iii) Cash
Payment in lieu of Full Value Award. In the event the Company or the surviving corporation fails, for any reason, to grant
the Full Value Award within 90 days following the consummation of the Transaction, then the Company shall pay, or shall cause
the surviving corporation to pay, to Executive, in cash, on each applicable vesting (or payment) date under this Section 2(e),
an amount equal to the then-fair market value of the shares underlying the Base Full Value Award and the Sponsor Award that vest
(or are paid) on each such applicable date, with such vesting/payment otherwise subject to the provisions of Section 2(e)(i) and
(ii), as applicable.

 

    -7-

     

    

 

(f) Relocation.
In order to assist with the move of Executive and Executive’s household from Wisconsin to the Washington, D.C. metropolitan
area, the Company will reimburse Executive for the following amounts: the amount (up to a cap of $50,000 in the aggregate) of
Executive’s actual and reasonable relocation expenses incurred for the following items: closing costs on the sale of Executive’s
home in Wisconsin and the transportation of Executive, and his family, and their personal property, from Wisconsin to the Washington,
D.C. metropolitan area, including air and ground transportation for Executive and his family, and including packing, storing,
insuring, shipping/trucking, and unpacking all such personal property (collectively, the “Moving Expenses”);
and the amount (up to a cap of $25,000 in the aggregate) of Executive’s actual and reasonable expenses incurred in connection
with obtaining and maintaining temporary housing in the Washington, D.C. metropolitan area from the beginning of the calendar
month in which the Start Date occurs through August 31, 2021, or, if earlier, the date Executive’s relocation is complete
(the “Temporary Housing Expenses” and, together with the Moving Expenses, the “Relocation
Payments”). In order to be eligible for the Relocation Payments, Executive must submit a request for reimbursement
to the Company with appropriate documentation substantiating the expense within sixty (60) days of incurring the expense. The
Relocation Payments shall be made to Executive, grossed up for all applicable taxes, within thirty (30) days of the date Executive
submits Executive’s valid reimbursement request with the documentation necessary to substantiate the expense. If Executive
voluntarily resigns from the Company other than for Good Reason or the Company terminates Executive’s employment for Cause
before the six month anniversary of the Start Date, Executive will be required to immediately return the gross pre-tax amount
of the Moving Expenses to the Company. In such case, Executive’s signature below authorizes the Company, to the fullest
extent permitted by law, to make deductions from any payment Executive is owed (including Executive’s final paycheck) to
repay all or a portion of the Relocation Payment. Executive agrees that, if any such deductions do not fully repay the Relocation
Payment that is owed to the Company, Executive will pay the Company the remaining balance within thirty (30) calendar days of
the last day of Executive’s employment with the Company.

 

3. Employee
Benefits. During the Employment Period, Executive shall be eligible to (a) receive paid time off (“PTO”)
in accordance with the Company’s PTO policy, as it may be in effect from time to time; (b) receive an automobile allowance
in accordance of $500 per month in accordance with the Company’s automobile policy, as it may be in effect from time to
time; and (c) participate in the employee benefit plans maintained by the Company and generally available to similarly situated
employees of the Company, subject in each case to the generally applicable terms and conditions of the plan or policy in question
and to the determinations of any Person or committee administering such employee benefit plan or policy. Except with respect to
the automobile allowance, the Company reserves the right to cancel or change the employee benefit plans, policies and programs
it offers to its employees at any time.

 

    -8-

     

    

 

4. Business
Expenses. The Company will reimburse Executive for necessary and reasonable business expenses incurred in connection with
Executive’s duties hereunder upon presentation of an itemized account and appropriate supporting documentation, all in accordance
with the Company’s generally applicable policies. In addition, the Company shall pay directly to Executive’s attorneys
within thirty days following Executive’s execution of this Agreement and his submission of appropriate supporting documentation,
all reasonable attorneys’ fees and expenses incurred by Executive in connection with the review, negotiation, drafting and
execution of this Agreement, prior agreements, and related agreements and arrangements, but in no event greater than $15,000 in
the aggregate.

 

5. Rights
Upon Termination. Except as expressly provided in Section 6, upon the termination of Executive’s Employment,
Executive shall only be entitled to (a) any accrued but unpaid Base Salary and PTO, (b) all other benefits earned, and expenses
to be reimbursed, as described in this Agreement or under any Company plan, policy or arrangement, and (c) such other compensation
or benefits as may be required by law (collectively, the “Accrued Benefits”).

 

6. Termination
Benefits.

 

(a) Death;
Disability; Termination without Cause; Resignation for Good Reason. If the Company (or any parent, subsidiary or successor
of the Company) terminates Executive’s employment with the Company other than for Cause, or Executive’s employment
terminates due to Executive becoming Disabled or Executive’s death at any time, or Executive resigns for Good Reason, then,
subject to Section 7, Executive or Executive’s estate (as the case may be) will be entitled to the following:

 

(i) Accrued
Compensation. All Accrued Benefits, paid when due.

 

(ii) Severance.

 

(1) Executive
will receive semi-monthly continuing payments of severance pay at a rate equal to Executive’s Base Salary as then in effect
(but without taking into account any reduction in Base Salary that gives rise to a termination for Good Reason) for period of
12 months following the date of termination and, for the avoidance of doubt, the payments will be less all required tax withholdings
and other applicable deductions, and will be paid in accordance with the Company’s regular payroll procedures commencing
on the Release Deadline (as defined in Section 7(a)), provided that the first payment shall include any amounts that would have
been paid to Executive if payment had commenced on the date of Executive’s separation from service;

 

(2) In
the event Executive’s employment is terminated in any calendar year prior to the date the Cash Bonus for the immediately
preceding year has been paid, Executive will receive the Cash Bonus for such prior year, the amount of which will be determined
in accordance with Section 2(b);

 

(3) Executive
will receive the Guaranteed Bonus for calendar year 2020, if not previously paid;

 

    -9-

     

    

 

(4) If
a Transaction has not occurred prior to the date of termination, Executive will remain vested in, and will retain the right to
receive, the portion of the Change in Control Bonus that was vested as of the date of termination; provided, however, that the
underlying Change in Control occurs prior to the seventh anniversary of the Start Date; and provided, further, that if a Change
in Control occurs within 6 months following the date of termination and such termination is not due to Disability or death, Executive
shall vest in, and receive, 100% of the Change in Control Bonus, and shall be entitled to receive up to 100% of the Change in
Control Bonus Kicker as such amount is determined in accordance with Section 2(d)(iv);

 

(5) If
a Transaction has occurred prior to the date of termination, Executive will remain vested in, and will retain all rights with
respect to, the portion of the shares underlying the Base Full Value Award that was vested as of the date of termination; provided,
however, that if any portion of the Sponsor Promote Earnout Shares are earned within 6 months following the date of termination
and such termination is not due to Disability or death, Executive shall vest in, and receive the portion of the Sponsor Award
that he would have received had his employment continued;

 

(6) If
a Transaction has occurred prior to the date of termination but Executive did not receive a Full Value Award and instead, under
Section 2(e)(iii), was entitled to a cash payment in lieu of the Full Value Award, Executive will remain entitled to a cash payment
in lieu of the Full Value Award in the amounts and on the dates provided under sub-clause (5) of this Section 6(a)(ii);

 

(7) If
Executive elects continuation coverage pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”)
for Executive and Executive’s eligible dependents, within the time period prescribed pursuant to COBRA, the Company will
reimburse Executive for the COBRA premiums for such coverage (at the coverage levels in effect immediately prior to Executive’s
termination or resignation) until the earliest of (I) the end of the period during which he is receiving continuing payments of
Base Salary under sub-clause (1) or sub-clause (8) of this Section 6(a)(ii), as applicable, (II) the maximum period of continuation
coverage required under COBRA, or (III) the date upon which Executive and/or Executive’s eligible dependents become covered
under similar plans. COBRA reimbursements will be made by the Company to Executive consistent with the Company’s normal
expense reimbursement policy and will be taxable to the extent required to avoid adverse consequences to Executive or the Company
under either Code Section 105(h) or the Patient Protection and Affordable Care Act of 2010.

 

    -10-

     

    

 

(8) Notwithstanding
anything to the contrary above, in the event Executive terminates his employment under clause (ii) of the definition of Good Reason
(i.e., because the Transition has not been completed within six months following the Start Date), then (I) with respect to sub-clause
(1) above, in lieu of 12 months of continued base salary, Executive shall be entitled to $900,000 (i.e., 24 months of Base Salary),
which amount shall be paid in 48 semi-monthly continuing payments of $18,750 following the date of termination, less all required
tax withholdings and other applicable deductions; and (II) with respect to sub-clauses (4) through (6) above, solely for purposes
of determining the time-based vested portion of the Change in Control Bonus pursuant to Section 2(d)(ii) or the Base Full Value
Award under Section 2(e)(i) or cash payment in lieu thereof under Section 2(e)(iii), as applicable, Executive’s date of
termination shall be deemed to be the one (1) year anniversary of the Start Date.

 

(b) Voluntary
Resignation; Termination for Cause. If Executive’s employment with the Company is terminated due to (i) Executive’s
voluntary resignation (other than for Good Reason) or (ii) the Company’s termination of Executive’s employment with
the Company for Cause, then Executive will receive the Accrued Benefits, but will not be entitled to any other compensation or
benefits from the Company except to the extent required by law (for example, COBRA). All Accrued Benefits shall in all cases be
paid within thirty (30) days of Executive’s termination of employment (or such earlier date as required by applicable law).

 

(c) Timing
of Payments. Subject to any specific timing provisions in Section 6(a) or 6(b), as applicable, or the provisions of Section
7, payment of the severance and benefits hereunder shall be made or commence to be made as soon as practicable following Executive’s
termination of employment.

 

(d) Exclusive
Remedy. In the event of a termination of Executive’s employment with the Company (or any parent, subsidiary or successor
of the Company), the provisions of this Section 6 are intended to be and are exclusive and in lieu of any other rights or remedies
to which Executive or the Company may otherwise be entitled, whether at law, tort or contract, in equity, or under this Agreement
(other than the payment of accrued but unpaid wages, as required by law, and any unreimbursed reimbursable expenses). Executive
will be entitled to no other severance, benefits, compensation or other payments or rights upon a termination of employment, including,
without limitation, any severance payments and/or benefits provided in the Employment Agreement, other than those benefits expressly
set forth in Section 6 of this Agreement or pursuant to written equity award agreements with the Company.

 

(e) No
Duty to Mitigate. Executive will not be required to mitigate the amount of any payment contemplated by this Agreement,
nor will any earnings that Executive may receive from any other source reduce any such payment.

 

    -11-

     

    

 

7. Conditions
to Receipt of Severance.

 

(a) Release
of Claims Agreement. The receipt of any severance payments or benefits pursuant to this Agreement is subject to Executive
or Executive’s estate (as the case may be) signing and not revoking a separation agreement and release of claims in a form
attached to this Agreement as Attachment A (the “Release”), which must become effective no later
than the sixtieth (60th) day following Executive’s termination of employment (the “Release Deadline”),
and if not, Executive or Executive’s estate (as the case may be) will forfeit any right to severance payments or benefits
under this Agreement. To become effective, the Release must be executed by Executive or Executive’s estate (as the case
may be) and any revocation periods (as required by statute, regulation, or otherwise) must have expired without Executive or Executive’s
estate (as the case may be) having revoked the Release. In addition, in no event will severance payments or benefits be paid or
provided until the Release actually becomes effective. If the termination of employment occurs at a time during the calendar year
where the Release Deadline could occur in the calendar year following the calendar year in which Executive’s termination
of employment occurs, then any severance payments or benefits under this Agreement that would be considered Deferred Payments
(as defined in Section 7(c)(i)) will be paid on the first payroll date to occur during the calendar year following the calendar
year in which such termination occurs, or such later time as required by (i) the payment schedule applicable to each payment or
benefit as set forth in Section 6, (ii) the date the Release becomes effective, or (iii) Section 7(c)(ii); provided that the first
payment shall include all amounts that would have been paid to Executive if payment had commenced on the date of Executive’s
termination of employment.

 

(b) Restrictive
Covenants. The receipt of any termination benefits pursuant to Section 6 will be subject to Executive not having
breached any material provisions of the Confidentiality Agreement (as defined in Section 10(a) below). In the event Executive
breaches the material provisions of the Confidentiality Agreement, as reasonably determined by the Board in good faith by a vote
of not less than two-thirds (2/3) of the Members of the full Board at a meeting called for such purpose at which Executive and
his attorney are given an opportunity to present, all continuing payments and benefits to which Executive may otherwise be entitled
pursuant to Section 6 will immediately cease (other than the Accrued Benefits).

 

(c) Section
409A.

 

(i) Notwithstanding
anything to the contrary in this Agreement, no severance pay or benefits to be paid or provided to Executive, if any, pursuant
to this Agreement that, when considered together with any other severance payments or separation benefits, are considered deferred
compensation not exempt under Section 409A (together, the “Deferred Payments”) will be paid or otherwise
provided until Executive has a “separation from service” within the meaning of Section 409A. And for purposes of this
Agreement, any reference to “termination of employment,” “termination” or any similar term shall be construed
to mean a “separation from service” within the meaning of Section 409A. Similarly, no severance payable to Executive,
if any, pursuant to this Agreement that otherwise would be exempt from Section 409A pursuant to Treasury Regulation Section 1.409A-1(b)(9)
will be payable until Executive has a “separation from service” within the meaning of Section 409A.

 

    -12-

     

    

 

(ii) Notwithstanding
anything to the contrary in this Agreement, if Executive is a “specified employee” within the meaning
of Section 409A at the time of Executive’s termination of employment (other than due to death), then the Deferred Payments,
if any, that are payable within the first six (6) months following Executive’s separation from service, will become payable
on the first payroll date that occurs on or after the date six (6) months and one (1) day following the date of Executive’s
separation from service. All subsequent Deferred Payments, if any, will be payable in accordance with the payment schedule applicable
to each payment or benefit. Notwithstanding anything herein to the contrary, if Executive dies following Executive’s separation
from service, but prior to the six (6) month anniversary of the separation from service, then any payments delayed in accordance
with this paragraph will be payable in a lump sum as soon as administratively practicable after the date of Executive’s
death and all other Deferred Payments will be payable in accordance with the payment schedule applicable to each payment or benefit.
Each payment, installment and benefit payable under this Agreement is intended to constitute a separate payment for purposes of
Section 1.409A-2(b)(2) of the Treasury Regulations.

 

(iii) Without
limitation, any amount paid under this Agreement that satisfies the requirements of the “short-term deferral” rule
set forth in Section 1.409A-1(b)(4) of the Treasury Regulations is not intended to constitute Deferred Payments for purposes of
clause (i) above.

 

(iv) Without
limitation, any amount paid under this Agreement that qualifies as a payment made as a result of an involuntary separation from
service pursuant to Section 1.409A-1(b)(9)(iii) of the Treasury Regulations that does not exceed the Section 409A Limit is not
intended to constitute Deferred Payments for purposes of clause (i) above. Any payment intended to qualify under this exemption
must be made within the allowable time period specified in Section 1.409A-1(b)(9)(iii) of the Treasury Regulations.

 

(v) To
the extent that reimbursements or in-kind benefits under this Agreement constitute non-exempt “nonqualified deferred compensation”
for purposes of Section 409A, (1) all reimbursements hereunder shall be made on or prior to the last day of the calendar year
following the calendar year in which the expense was incurred by Executive, (2) any right to reimbursement or in-kind benefits
shall not be subject to liquidation or exchange for another benefit, and (3) the amount of expenses eligible for reimbursement
or in-kind benefits provided in any calendar year shall not in any way affect the expenses eligible for reimbursement or in-kind
benefits to be provided, in any other calendar year.

 

(vi) The
payments and benefits provided under Sections 6(a) and Section 6(b) are intended to be exempt from or comply with the requirements
of Section 409A so that none of the severance payments and benefits to be provided hereunder will be subject to the additional
tax imposed under Section 409A, and any ambiguities or ambiguous terms herein will be interpreted to be exempt or so comply. The
Company and Executive agree to work together in good faith to consider amendments to this Agreement and to take such reasonable
actions that are necessary, appropriate or desirable to avoid imposition of any additional tax or income recognition prior to
actual payment to Executive under Section 409A.

 

    -13-

     

    

 

8. Definition
of Terms. The following terms referred to in this Agreement will have the following meanings:

 

(a) Cause.
“Cause” means Executive’s:

 

(i) willful
failure to reasonably and substantially perform Executive’s duties (other than as a result of physical or mental illness
or injury);

 

(ii) willful
misconduct, intentional misrepresentation or gross negligence which causes injury (or, in the case of willful misconduct, significant
injury) to the Company or any of its affiliates (whether financially, reputationally or otherwise);

 

(iii) commission
of an act of fraud, embezzlement, misappropriation or a breach by Executive of Executive’s fiduciary duty or duty of loyalty
to the Company or its affiliates;

 

(iv) indictment,
receipt of a charge or conviction for (or plea of guilty or nolo contendere with respect to) any felony or any crime involving
dishonesty or moral turpitude;

 

(v) unlawful
use (including being under the influence) or possession of illegal drugs on the Company’s premises; or

 

(vi) breach
by Executive of the material terms of any agreement with the Company or any affiliate or any material Company policies (including
without limitation any policy related to sexual harassment, assault or fraternization).

 

Notwithstanding
the foregoing, the Company may not terminate Executive’s employment for Cause under clauses (i), (ii) or (vi) of this definition
unless (A) the Company or the Board has provided notice to Executive setting forth in reasonable detail the specific conduct
purporting to constitute Cause within ninety (90) days of the date the Company or the Board first becomes aware of its existence,
(B) Executive has failed to cure such conduct (if capable of cure) within fifteen (15) days following the date of receipt
of such notice, and (C) the Board or the Company has terminated Executive’s employment within thirty (30) days following
such failure to cure. Notwithstanding the foregoing, if following the termination of Executive’s services, it is determined
that Executive’s services could have been terminated for Cause, as such term is defined above, Executive’s services
shall, at the election of the Board, be deemed to have been terminated for Cause retroactively to the date the events giving rise
to Cause occurred.

 

(b) Code.
“Code” means the Internal Revenue Code of 1986, as amended.

 

(c) Disability.
“Disability” or “Disabled” means that Executive is unable to engage in any substantial gainful activity
by reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted,
or can be expected to last, for a continuous period of not less than one (1) year.

 

    -14-

     

    

 

(d) Good
Reason. “Good Reason” means the occurrence of any of the following events without the Executive’s prior
written consent: (i) any reduction in Base Salary or Target Bonus Percentage; (ii) the failure to complete the Transition
within six months following the Start Date; (iii) any material diminution in the Executive’s title, authority, duties
or responsibilities as President or Chief Executive Officer, as applicable; (iv) a relocation of the Executive’s
principal place of employment such that Executive’s normal daily one-way commute is increased by more than 25 miles as compared
to Executive’s principal place of employment as of the Start Date; or (v) a breach by the Company of any material
obligation under this Agreement or any written agreement between the Executive and the Company; provided, however, that no act
or lack thereof arising from a failure of the parties to agree on the Performance Goals shall be deemed an event giving rise to
Good Reason. Notwithstanding the foregoing, Executive may not terminate his employment for Good Reason unless (A) the Executive
has provided notice to the Board setting forth in reasonable detail the specific conduct of the Company or the Board purporting
to constitute Good Reason within ninety (90) days of the date the Executive first becomes aware of its existence, (B) the
Board has failed to cure such conduct within fifteen (15) days following the date of receipt of such notice, and (C) the
Executive has terminated his employment within thirty (30) days following such failure to cure.

 

(e) Governmental
Authority. “Governmental Authority” means any federal, state, municipal, foreign or other government, governmental
department, commission, board, bureau, agency or instrumentality, or any private or public court or tribunal.

 

(f) Person.
“Person” shall be construed in the broadest sense and means and includes any natural person, a partnership, a corporation,
an association, a joint stock company, a limited liability company, a trust, a joint venture, an unincorporated organization and
other entity or Governmental Authority.

 

(g) Section
409A. “Section 409A” means Section 409A of the Code, and the final regulations and any guidance promulgated
thereunder or any state law equivalent.

 

(h) Section
409A Limit. “Section 409A Limit” shall mean two (2) times the lesser of: (i) Executive’s annualized
compensation based upon the annual rate of pay paid to Executive during Executive’s taxable year preceding Executive’s
taxable year of his or her separation from service as determined under Treasury Regulation Section 1.409A-1(b)(9)(iii)(A)(1) and
any Internal Revenue Service guidance issued with respect thereto; or (ii) the maximum amount that may be taken into account under
a qualified plan pursuant to Section 401(a)(17) of the Code for the year in which Executive’s separation from service occurred.

 

    -15-

     

    

 

9. Golden
Parachute.

 

(a) Anything
in this Agreement to the contrary notwithstanding, if any payment or benefit Executive would receive from the Company or otherwise
(“Payment”) would (i) constitute a “parachute payment” within the meaning of Section 280G
of the Code; and (ii) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the “Excise
Tax”), then such Payment shall be equal to the Reduced Amount. The “Reduced Amount”
shall be either (x) the largest portion of the Payment that would result in no portion of the Payment being subject to
the Excise Tax; or (y) the largest portion, up to and including the total, of the Payment, whichever amount, after taking
into account all applicable federal, state and local employment taxes, income taxes, and the Excise Tax (all computed at the highest
applicable marginal rate), results in Executive’s receipt, on an after-tax basis, of the greater amount of the Payment.
Any reduction made pursuant to this Section 9(a) shall be made in accordance with the following order of priority: (i) stock options
whose exercise price exceeds the fair market value of the optioned stock (“Underwater Options”) (ii)
Full Credit Payments (as defined below) that are payable in cash, (iii) non-cash Full Credit Payments that are taxable, (iv) non-cash
Full Credit Payments that are not taxable (v) Partial Credit Payments (as defined below) and (vi) non-cash employee welfare benefits.
In each case, reductions shall be made in reverse chronological order such that the payment or benefit owed on the latest date
following the occurrence of the event triggering the excise tax will be the first payment or benefit to be reduced (with reductions
made pro-rata in the event payments or benefits are owed at the same time). “Full Credit Payment” means
a payment, distribution or benefit, whether paid or payable or distributed or distributable pursuant to the terms of this Agreement
or otherwise, that if reduced in value by one dollar reduces the amount of the parachute payment (as defined in Section 280G of
the Code) by one dollar, determined as if such payment, distribution or benefit had been paid or distributed on the date of the
event triggering the excise tax. “Partial Credit Payment” means any payment, distribution or benefit
that is not a Full Credit Payment.

 

(b) A
nationally recognized certified public accounting firm selected by the Company (the “Accounting Firm”)
shall perform the foregoing calculations related to the Excise Tax. If a reduction is required pursuant to Section 9(a), the Accounting
Firm shall administer the ordering of the reduction as set forth in Section 9(a). The Company shall bear all expenses with respect
to the determinations by such accounting firm required to be made hereunder.

 

(c) The
Accounting Firm engaged to make the determinations hereunder shall provide its calculations, together with detailed supporting
documentation, to Executive and the Company within fifteen (15) calendar days after the date on which Executive’s right
to a Payment is triggered. Any good faith determinations of the Accounting Firm made hereunder shall be final, binding, and conclusive
upon Executive and the Company.

 

(d) Notwithstanding
anything to the contrary in Section 9(a), if any Payment that would be otherwise reduced pursuant to Section 9(a) would not be
so reduced if the stockholder approval requirements of Section 280G(b)(5) of the Code are capable of being satisfied, the Company
will use its reasonable best efforts to cause such payments to be timely submitted for such approval in accordance with such requirements.

 

10. Pre-Employment
Conditions.

 

(a) Confidentiality
Agreement. Executive’s acceptance of this offer and Executive’s Employment with the Company is contingent
upon the execution, and delivery to an officer of the Company, of the Company’s Employee Nondisclosure, Non-Solicitation,
Confidentiality and Developments Agreement, a copy of which is attached hereto as Attachment B for Executive’s review
and execution (the “Confidentiality Agreement”), prior to or on Executive’s Start Date.

 

    -16-

     

    

 

(b) Right
to Work. For purposes of federal immigration law, Executive will be required, if Executive has not already, to provide
to the Company documentary evidence of Executive’s identity and eligibility for employment in the United States. Such documentation
must be provided to the Company within three (3) business days of the Start Date, or our Employment relationship with Executive
may be terminated.

 

(c) Verification
of Information. This Agreement is also contingent upon the successful verification of the information Executive provided
to the Company during Executive’s application process, as well as a general background check performed by the Company to
confirm Executive’s suitability for Employment. By accepting this Agreement, Executive warrants that all information provided
by Executive is true and correct to the best of Executive’s knowledge, Executive agrees to execute any and all documentation
necessary for the Company to conduct a background check and Executive expressly releases the Company from any claim or cause of
action arising out of the Company’s verification of such information.

 

11. Arbitration.

 

(a) Arbitration.
In consideration of Executive’s Employment with the Company, its promise to arbitrate all employment-related disputes,
and Executive’s receipt of the compensation, pay raises and other benefits paid to Executive by the Company, at present
and in the future, Executive agrees that any and all controversies, claims, or disputes with anyone (including the Company and
any employee, officer, director, shareholder or benefit plan of the Company in their capacity as such or otherwise) arising out
of, relating to, or resulting from Executive’s Employment with the Company or termination thereof, including any breach
of this Agreement, will be subject to binding arbitration pursuant to Virginia law. The Federal Arbitration Act shall also apply
with full force and effect.

 

(b) Dispute
Resolution. Disputes that Executive agrees to arbitrate, and thereby agrees to waive any right to a jury trial, include
any statutory claims under local, state, or federal law, including, but not limited to, claims under Title VII of the Civil Rights
Act of 1964, the Americans with Disabilities Act of 1990, the Age Discrimination in Employment Act of 1967, the Older Workers
Benefit Protection Act, the Sarbanes Oxley Act, the Worker Adjustment and Retraining Notification Act, the Virginia Human Rights
Act, the Virginia Values Act, the Virginia Labor Code, claims of harassment, discrimination, and wrongful termination, and any
statutory or common law claims. Executive further understands that this agreement to arbitrate also applies to any disputes that
the Company may have with Executive.

 

    -17-

     

    

 

(c) Procedure.
Executive agrees that any arbitration will be administered by Judicial Arbitration & Mediation Services, Inc. (“JAMS”),
pursuant to its Employment Arbitration Rules & Procedures (the “JAMS Rules”). The arbitrator shall
have the power to decide any motions brought by any party to the arbitration, including motions for summary judgment and/or adjudication,
motions to dismiss and demurrers, and motions for class certification, prior to any arbitration hearing. The arbitrator shall
have the power to award any remedies available under applicable law, and the arbitrator shall award attorneys’ fees and
costs to the prevailing party, except as prohibited by law. The Company will pay for any administrative or hearing fees charged
by the administrator or JAMS, and all arbitrator’s fees, except that Executive shall pay any filing fees associated with
any arbitration that Executive initiates, but only so much of the filing fee as Executive would have instead paid had Executive
filed a complaint in a court of law. Executive agrees that the arbitrator shall administer and conduct any arbitration in accordance
with Virginia law, and that the arbitrator shall apply substantive and procedural Virginia law to any dispute or claim, without
reference to the rules of conflict of law. To the extent that the JAMS Rules conflict with Virginia law, Virginia law shall take
precedence. The decision of the arbitrator shall be in writing. Any arbitration under this Agreement shall be conducted in Virginia.

 

(d) Remedy.
Arbitration shall be the sole, exclusive, and final remedy for any dispute between Executive and the Company. Accordingly,
except as provided by this Agreement, neither Executive nor the Company will be permitted to pursue court action regarding claims
that are subject to arbitration. Notwithstanding, the arbitrator will not have the authority to disregard or refuse to enforce
any lawful Company policy, and the arbitrator will not order or require the Company to adopt a policy not otherwise required by
law that the Company has not adopted.

 

(e) Administrative
Relief. Executive is not prohibited from pursuing an administrative claim with a local, state, or federal administrative
body or government agency that is authorized to enforce or administer laws related to employment, including, but not limited to,
the Department of Fair Employment and Housing, the Equal Employment Opportunity Commission, the National Labor Relations Board,
or the Workers’ Compensation Board. However, Executive may not pursue court action regarding any such claim, except as permitted
by law.

 

(f) Voluntary
Nature of Agreement. Executive acknowledges and agrees that Executive is executing this Agreement voluntarily and without
any duress or undue influence by the Company or anyone else. Executive further acknowledges and agrees that Executive has carefully
read this Agreement and that Executive has asked any questions needed for Executive to understand the terms, consequences and
binding effect of this Agreement and fully understands it, including that EXECUTIVE IS WAIVING EXECUTIVE’S RIGHT TO
A JURY TRIAL.

 

(g) Independent
Advice. Executive acknowledges that Executive has been advised to obtain independent advice and legal counsel to advise
Executive concerning this Agreement, and that Executive has either done so or has knowingly waived that opportunity of Executive’s
own free choice. Neither the Company nor any attorneys for the Company have advised Executive concerning this Agreement, and Executive
is relying solely upon the advice of Executive’s own independent counsel (if any); nor has the Company or any attorneys
for the Company coerced, used undue influence, or otherwise induced Executive to enter into this Agreement.

 

    -18-

     

    

 

12. Successors.

 

(a) Company’s
Successors. This Agreement shall be binding upon any successor (whether direct or indirect and whether by purchase, lease,
merger, consolidation, liquidation or otherwise) to all or substantially all of the Company’s business and/or assets. For
all purposes under this Agreement, the term “Company” shall include any successor to the Company’s
business or assets that become bound by this Agreement or any affiliate of any such successor that employs Executive.

 

(b) Executive’s
Successors. This Agreement and all of Executive’s rights hereunder shall inure to the benefit of, and be enforceable
by, Executive’s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees
and legatees.

 

13. Miscellaneous
Provisions.

 

(a) Indemnification.
The Company shall indemnify Executive to the maximum extent permitted by applicable law and the Company’s Bylaws with respect
to Executive’s service and Executive shall also be covered under a directors and officers liability insurance policy paid
for by the Company to the extent that the Company maintains such a liability insurance policy now or in the future.

 

(b) Headings.
All captions and section headings used in this Agreement are for convenient reference only and do not form a part of this Agreement.

 

(c) Notice.

 

(i) General.
Notices and all other communications contemplated by this Agreement shall be in writing and shall be deemed to have been duly
given when personally delivered or when mailed by U.S. registered or certified mail, return receipt requested and postage prepaid.
In Executive’s case, mailed notices shall be addressed to Executive at the home address that Executive most recently communicated
to the Company in writing. In the case of the Company, mailed notices shall be addressed to its corporate headquarters, and all
notices shall be directed to the attention of its Secretary.

 

(ii) Notice
of Termination. Any termination by the Company for Cause or by Executive for Good Reason will be communicated by a notice
of termination to the other party hereto given in accordance with Section 13(c)(i) of this Agreement. Such notice will indicate
the specific termination provision in this Agreement relied upon, will set forth in reasonable detail the facts and circumstances
claimed to provide a basis for termination under the provision so indicated, and will specify the termination date (which will
be not more than thirty (30) days after the giving of such notice), subject to any applicable cure period. The failure by Executive
or the Company to include in the notice any fact or circumstance which contributes to a showing of Good Reason or Cause, as applicable,
will not waive any right of Executive or the Company, as applicable, hereunder or preclude Executive or the Company, as applicable,
from asserting such fact or circumstance in enforcing his or her or its rights hereunder, as applicable.

 

    -19-

     

    

 

(d) Modifications
and Waivers. No provision of this Agreement shall be modified, waived or discharged unless the modification, waiver or
discharge is agreed to in writing and signed by Executive and by an authorized officer of the Company (other than Executive).
No waiver by either party of any breach of, or of compliance with, any condition or provision of this Agreement by the other party
shall be considered a waiver of any other condition or provision or of the same condition or provision at another time.

 

(e) Whole
Agreement. No other agreements, representations or understandings (whether oral or written and whether express or implied)
that are not expressly set forth in this Agreement have been made or entered into by either party with respect to the subject
matter hereof. This Agreement and the Confidentiality Agreement contain the entire understanding of the parties with respect to
the subject matter hereof.

 

(f) Withholding
Taxes. All payments made under this Agreement shall be subject to reduction to reflect taxes or other deductions required
to be withheld by law.

 

(g) Choice
of Law and Severability. This Agreement shall be interpreted in accordance with the laws of the Commonwealth of Virginia,
without giving effect to provisions governing the choice of law. If any provision of this Agreement becomes or is deemed invalid,
illegal or unenforceable in any applicable jurisdiction by reason of the scope, extent or duration of its coverage, then such
provision shall be deemed amended to the minimum extent necessary to conform to applicable law so as to be valid and enforceable
or, if such provision cannot be so amended without materially altering the intention of the parties, then such provision shall
be stricken and the remainder of this Agreement shall continue in full force and effect. If any provision of this Agreement is
rendered illegal by any present or future statute, law, ordinance or regulation (collectively, the “Law”)
then that provision shall be curtailed or limited only to the minimum extent necessary to bring the provision into compliance
with the Law. All the other terms and provisions of this Agreement shall continue in full force and effect without impairment
or limitation.

 

(h) No
Assignment. This Agreement and all of Executive’s rights and obligations hereunder are personal to Executive and
may not be transferred or assigned by Executive at any time. The Company may assign its rights under this Agreement to any entity
that assumes the Company’s obligations hereunder in connection with any sale or transfer to such entity of all or a substantial
portion of the Company’s assets.

 

(i) Acknowledgment.
Executive acknowledges that Executive has had the opportunity to discuss this matter with and obtain advice from Executive’s
personal attorney, has had sufficient time to, and has carefully read and fully understood all the provisions of this Agreement,
and is knowingly and voluntarily entering into this Agreement.

 

(j) Counterparts.
This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together
shall constitute one and the same instrument. Execution of a facsimile copy will have the same force and effect as execution of
an original, and a facsimile signature will be deemed an original and valid signature.

 

(k) Electronic
Delivery. The Company may, in its sole discretion, decide to deliver any documents related to this Agreement by electronic
means. Executive hereby consents to receive such documents by electronic delivery.

 

[Signature
Page Follows]

  

    -20-

     

    

 

After
you have had an opportunity to review this Agreement, please feel free to contact me if you have any questions or comments. To
indicate your acceptance of this Agreement, please sign and date this letter in the space provided below and return it to the
Company.

 

	 	Very truly yours,
	 	 
	 	SOC TELEMED
	 	 
	 	By:	/s/
Paul Ricci
	 	(Signature)
	 	 
	 	Name:  	Paul Ricci                                   
	 	 
	 	Title: 	Chairman & CEO

 

ACCEPTED
AND AGREED:

 

JOHN
KALIX

  

	/s/ John Kalix	 
	(Signature)	 
	 	 
	6/25/20	 
	Date	 

 

		Attachment
                          A:	Form
of Separation Agreement and Release of Claims

 

		Attachment
                          B:	Employee
Nondisclosure, Non-Solicitation, Confidentiality and Developments Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00315-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00315-of-00352.parquet"}]]